General examination and investigation of persons without complaint and reported diagnosis

Z21_GENERAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z00 Cause of death: ICD-10 — Z00 2 out of 7 registries used, show all original rules.	64191
4. Check minimum number of events None	64191
5. Include endpoints None	64191
6. Filter based on genotype QC (FinnGen only)	61949

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z[0-1]

NAME	Z21_GENERAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS
CONTROL_EXCLUDE	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z00
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z00
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to General examination and investigation of persons without complaint and reported diagnosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	61949	39088	22861
Unadjusted period prevalence (%)	12.61	13.87	10.47
Median age at first event (years)	47.57	43.84	53.96

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
44382: Matched controls
231576

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z02.7

ICD-10 Finland

Issue of medical certificate

2.4

323.3

2693

5988

T89

ICPC

Diabetes insulin dependent

3.6

323.3

1358

2011

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

322.0

3050

7197

XKD00

NOMESCO Finland

Uroflowmetry

1.9

321.3

5276

15404

XG410

NOMESCO Finland

Flow-volume spirometry

3.9

320.0

1205

1642

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

319.7

14993

57974

M01AE02

ATC

naproxen; oral, rectal

1.5

319.6

21605

90187

D01

ICPC

Abdominal pain/cramps general

2.0

319.5

4126

11058

SPAT1059

SPAT

Spirometry at the office

2.9

319.1

1892

3512

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

318.8

15360

59734

R13

ICD-10 Finland

Dysphagia

2.7

318.5

2220

4510

R05

ICD-10 Finland

Cough

1.7

318.1

7198

23211

XA800

NOMESCO Finland

Neuropsychological investigation

3.2

318.0

1616

2728

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.8

317.8

687

538

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.8

317.5

1980

3784

N05BA06

ATC

lorazepam; systemic, sublingual

2.8

317.1

2008

3871

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

316.9

19884

81698

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

316.6

4526

12590

A10AE04

ATC

insulin glargine; parenteral

2.3

316.0

3075

7341

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

315.4

4803

13661

A28

ICPC

Limited function/disability NOS

1.9

314.7

5031

14550

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

313.6

3257

7996

Z29

ICPC

Social problem NOS

4.6

313.0

968

1115

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

312.0

3708

9619

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

21.7

312.0

375

M48.0

ICD-10 Finland

Spinal stenosis

2.1

311.6

3725

9685

J01DA01

ATC

[U] cefalexin

1.5

311.6

23621

100693

N05AB03

ATC

perphenazine; systemic, rectal

3.3

311.0

1502

2452

AN1

Coronary angiography

2.2

310.5

3452

8718

L16

ICPC

Ankle symptom/complaint

2.0

310.3

4024

10796

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

3.4

309.7

1396

2174

A46

ICD-10 Finland

Erysipelas

1.9

308.7

5005

14537

T90

ICPC

Diabetes non-insulin dependent

1.7

307.9

7492

24635

Z2446

NOMESCO Finland

Social worker

2.5

307.7

2416

5216

KHV, ,

NOMESCO Finland

14.2

307.7

547

203

N07BB01

ATC

disulfiram; oral

3.3

307.7

2038

3373

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.4

307.7

1496

2339

R50.9

ICD-10 Finland

Fever, unspecified

2.3

307.7

6186

15328

R5599

NOMESCO Finland

Other rehabilitation service

4.5

307.7

1114

1314

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

307.7

8164

22913

SPAT1216

SPAT

Assessment of functional ability

3.6

307.7

7254

12013

SPAT1360

SPAT

Extensive global examination

3.3

307.7

3098

5189

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

307.7

3246

7692

P01AB01

ATC

metronidazole; oral, rectal

1.7

307.7

14397

52073

XCK00

NOMESCO Finland

Perimetry

3.6

307.7

2108

3163

N05AA02

ATC

levomepromazine; systemic

3.6

307.7

1866

2782

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

27.8

307.7

490

N02BE01

ATC

paracetamol; systemic, rectal

2.6

307.7

38006

160614

WZC30

NOMESCO Finland

Teaching

2.6

307.7

7002

15490

Z97.4

ICD-10 Finland

Presence of external hearing-aid

6.9

307.7

1680

1322

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

307.7

7250

21983

N06AB06

ATC

sertraline; oral

3.0

307.7

5460

10434

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

307.7

8980

24825

N06AB10

ATC

escitalopram; oral

2.6

307.7

9944

23345

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.1

307.7

4934

8946

N05BA01

ATC

diazepam; systemic, rectal

2.6

307.7

5624

12040

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

9.8

307.7

1072

584

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

307.7

11061

24951

N05BE01

ATC

buspirone; oral

3.9

307.7

1248

1686

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

5.7

307.7

3480

3402

Z01.0

ICD-10 Finland

Examination of eyes and vision

17.5

307.7

7165

2522

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.3

307.7

14154

38961

PLAK2, ,

NOMESCO Finland

11.0

307.7

511

244

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

307.7

28574

122563

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

307.7

2779

5898

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.7

307.7

4527

6930

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

4.9

307.7

1365

1495

L03

ICPC

Low back symptom/complaint

2.1

307.7

11079

31340

SPAT1263

SPAT

Sampling

2.1

307.7

18100

58203

G47.3

ICD-10 Finland

Sleep apnoea

1.9

307.7

8220

25099

N05BA04

ATC

oxazepam; oral

2.8

307.7

12522

28783

XQ802

NOMESCO Finland

Epicutan test

5.4

307.7

1110

1104

N05AH03

ATC

olanzapine; systemic

4.6

307.7

3792

4598

RD211, ,

NOMESCO Finland

13.6

307.7

3868

1618

N05CF01

ATC

zopiclone; oral

2.1

307.7

13143

37999

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

307.7

14981

57326

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

307.7

7895

24860

L08

ICPC

Shoulder symptom/complaint

1.8

307.7

7490

23105

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

307.7

4399

11328

N05BA12

ATC

alprazolam; oral

2.4

307.7

3775

8596

U02

ICPC

Urinary frequency/urgency

2.1

307.7

4746

12562

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.0

307.7

12454

37731

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

307.7

8392

27110

J01AA02

ATC

doxycycline; systemic

1.6

307.7

30203

130600

A02BC03

ATC

lansoprazole; oral

1.8

307.7

9960

31776

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.2

307.7

1988

2529

N02BF01

ATC

gabapentin; oral

2.6

307.7

2824

5971

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.3

307.7

2004

1712

N06AX03

ATC

mianserin; oral

3.1

307.7

1818

3147

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

307.7

8078

24060

J01CA04

ATC

amoxicillin; systemic

1.6

307.7

33625

152850

R96

ICPC

Asthma

2.3

307.7

3193

7562

SPAT1153

SPAT

Removal of sutures

2.1

307.7

12513

36665

SPAT1283

SPAT

Restricted health certificate

1.8

307.7

7288

23077

M03BX02

ATC

tizanidine; oral

1.6

307.7

23962

98355

EBA00

NOMESCO Finland

Extraction of tooth

1.7

307.7

14534

51230

Z3231

NOMESCO Finland

Registered nurse

2.4

307.7

11849

30208

L15

ICPC

Knee symptom/complaint

1.8

307.7

8119

26164

N06AX22

ATC

agomelatine; oral

5.1

307.7

1143

1192

X58

ICD-10 Finland

Exposure to other specified factors

2.0

307.7

5596

15306

F61.0

ICD-10 Finland

Mixed personality disorders

7.1

307.7

975

726

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

307.7

9228

28384

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

307.7

5077

11506

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

6.0

307.7

796

706

N06AX21

ATC

duloxetine; oral

3.5

307.7

5538

9088

TQW80

NOMESCO Finland

Local dermatologic skincare

5.6

307.7

1308

1250

N06AB03

ATC

fluoxetine; oral

2.6

307.7

5241

11195

XCH00

NOMESCO Finland

Eye pressure measurement

3.8

307.7

1482

2083

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

12.6

307.7

1525

651

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

307.7

22734

83934

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.6

307.7

2678

4009

A02BC02

ATC

pantoprazole; systemic

2.1

307.7

27460

100683

SPAT1234

SPAT

Support of social functional capacity

3.6

307.7

2163

3290

R07.4

ICD-10 Finland

Chest pain, unspecified

2.2

307.7

10730

28981

F39

ICD-10 Finland

Unspecified mood [affective] disorder

5.6

307.7

967

918

Z01.8

ICD-10 Finland

Other specified special examinations

9.8

307.7

9633

6344

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

6.5

307.7

5354

4810

SPAT1359

SPAT

Use of symptom diary

9.6

307.7

1719

965

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

307.7

9654

32996

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.5

307.7

5383

12150

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.9

307.7

3953

4523

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

5.8

307.7

2590

2435

R52.9

ICD-10 Finland

Pain, unspecified

2.4

307.7

3680

8293

M25.5

ICD-10 Finland

Pain in joint

1.8

307.7

11820

38232

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

307.7

8072

26292

P76

ICPC

Depressive disorder

3.4

307.7

3296

5270

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

3.3

307.7

1867

3026

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.3

307.7

4824

11452

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.8

307.7

1616

2277

H02AB06

ATC

prednisolone; systemic

1.9

307.7

18658

63454

L01

ICPC

Neck symptom/complaint

2.1

307.7

5745

15102

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

6.4

307.7

1204

1002

SFA30

NOMESCO Finland

Three-surface restoration

1.6

307.7

15541

59531

DFF15

NOMESCO Finland

Speech audiometry

7.4

307.7

1729

1256

N03AG01

ATC

valproic acid; systemic, rectal

4.2

307.7

3200

4193

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

307.7

10035

33370

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

307.7

12033

30301

SPAT1249

SPAT

Treatment-related counselling outside office

2.2

307.7

17979

54195

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

2.6

307.7

5057

10743

J01FF01

ATC

clindamycin; systemic

1.8

307.7

10055

32624

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

5.7

307.7

1105

1033

HMAK, ,

NOMESCO Finland

2.9

307.7

6181

12291

N06AB05

ATC

paroxetine; oral

2.9

307.7

2518

4676

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

7.4

307.7

1131

819

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.1

307.7

1896

3269

SPAT1097

SPAT

Recording of ECG

2.2

307.7

5047

12873

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

7.7

307.7

1383

962

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

307.7

7185

19412

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

4.9

307.7

2083

2304

A04

ICPC

Weakness/tiredness general

2.3

307.7

5744

13783

R21

ICPC

Throat symptom/complaint

1.8

307.7

8552

26961

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.6

307.7

13031

48295

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.5

307.7

5486

9037

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

4.7

307.7

1454

1659

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

4.5

307.7

2264

2729

F41.09

ICD-10 Finland

UNS Panic Syndrome

4.0

307.7

1345

1812

SPAT1229

SPAT

Assessment of need for aid

3.1

307.7

2910

5136

N06AX16

ATC

venlafaxine; oral

3.4

307.7

7284

12720

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

307.7

10950

34913

K02.1

ICD-10 Finland

Caries of dentine

1.7

307.7

24660

97114

N06AX26

ATC

vortioxetine; oral

3.2

307.7

3535

6140

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

307.7

4495

12287

XQ800

NOMESCO Finland

Prick test

4.4

307.7

2505

3123

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

307.7

7675

24618

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.9

307.7

2602

4834

M79.1

ICD-10 Finland

Myalgia

2.1

307.7

5237

14046

Z04.3

ICD-10 Finland

Examination and observation following other accident

75.3

307.7

794

DFF00

NOMESCO Finland

Pure tone audiometry

4.5

307.7

3413

4235

N02AA05

ATC

oxycodone; systemic

2.3

307.7

6612

16135

Z00.0

ICD-10 Finland

General medical examination

20.8

307.7

24361

12808

R5140

NOMESCO Finland

Monitoring the use of the aid

2.4

307.7

4165

9489

P74

ICPC

Anxiety disorder/anxiety state

3.4

307.7

1998

3166

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

5.8

307.7

1486

1365

S06.0

ICD-10 Finland

Concussion

2.5

307.7

4514

10136

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

9.4

307.7

837

471

XA402

NOMESCO Finland

ENMG

13.2

307.7

1123

453

P06

ICPC

Sleep disturbance

2.2

307.7

4670

11989

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

307.7

4054

8687

J45.8

ICD-10 Finland

Mixed asthma

4.3

307.7

1286

1608

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.1

307.7

2898

5063

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

484.0

307.7

3266

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

26.2

307.7

571

115

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

8.4

307.7

756

474

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.5

307.7

3906

6298

N05CD07

ATC

temazepam; oral

2.1

307.7

4177

10868

N06AB04

ATC

citalopram; systemic

2.6

307.7

9410

21554

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

307.7

7505

20928

P15

ICPC

Chronic alcohol abuse

3.8

307.7

1404

1968

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

6.2

307.7

1671

1458

SPAT1260

SPAT

Consultation of another employee

2.1

307.7

7178

19313

N05CF02

ATC

zolpidem; oral

2.0

307.7

6580

18152

R06AE07

ATC

cetirizine; oral

1.6

307.7

16466

63440

P29

ICPC

Psychological sympt/compl other

3.8

307.7

3945

5752

SPAT1254

SPAT

Administration of medicine

2.6

307.7

6642

14512

A01

ICPC

Pain general/multiple sites

2.5

307.7

3212

6876

SPAT1307

SPAT

Psychosocial counselling and guidance

3.1

307.7

3248

5718

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

31.9

307.7

448

KMAK, ,

NOMESCO Finland

1.7

307.7

20881

78330

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.5

307.7

1201

1438

C07AB07

ATC

bisoprolol; oral

1.8

307.7

17422

61162

N05AF03

ATC

chlorprothixene; systemic

4.4

307.7

1304

1574

R5120

NOMESCO Finland

Preparation of an aid

6.7

307.7

1145

916

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

13.5

307.7

1364

541

N02AX02

ATC

tramadol; systemic, rectal

2.0

307.7

17008

54903

S15

ICPC

Foreign body in skin

2.9

307.7

2641

4942

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

6.0

307.7

1152

1020

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.0

307.7

2501

4569

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

307.7

4820

10569

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

20.8

307.7

2472

655

N03AE01

ATC

clonazepam; systemic

3.7

307.7

2490

3705

UJF32

NOMESCO Finland

Coloscopy

2.3

307.7

9088

22956

C03CA01

ATC

furosemide; systemic

1.8

307.7

9775

32126

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

307.7

6653

17005

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.9

307.7

6586

19108

N06AX12

ATC

bupropion; oral

3.5

307.7

3769

6038

M54.5

ICD-10 Finland

Low back pain

2.1

307.7

15215

45220

-1, ,

NOMESCO Finland

2.1

307.7

14783

44600

R51.80

ICD-10 Finland

Headache

3.0

307.7

7020

13765

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

307.7

6816

17936

F34.1

ICD-10 Finland

Dysthymia

4.4

307.7

1761

2141

SPAT1325

SPAT

Vaccination

1.6

307.7

12212

43738

AA1AD

NOMESCO Finland

CT of head and brain

1.8

307.7

8943

28524

K59.09

ICD-10 Finland

Constipation, unspecified

3.0

307.7

2423

4370

A03

ICPC

Fever

1.8

307.7

6612

20420

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.7

307.7

6239

13267

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

307.7

7086

17900

L17

ICPC

Foot/toe symptom/complaint

1.8

307.7

10178

32405

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

6.8

307.7

771

597

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

30.7

307.7

1303

228

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

307.7

30678

122722

RF410, ,

NOMESCO Finland

17.6

307.7

925

280

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

307.7

17614

61091

A06AD11

ATC

lactulose; oral

2.0

307.7

5048

13805

G44.2

ICD-10 Finland

Tension-type headache

2.4

307.7

5323

12544

N03AX12

ATC

[U] gabapentin; oral

3.1

307.7

7046

13360

ZYC01

NOMESCO Finland

Remote contact by phone

5.0

307.7

3825

4250

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

307.7

16687

57051

SFA10

NOMESCO Finland

One-surface restoration

1.7

307.7

22449

86423

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

6.2

307.7

1316

1132

K30

ICD-10 Finland

Functional dyspepsia

2.1

307.7

3772

9677

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.7

307.7

4682

5708

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

307.7

14287

47376

ZX120

NOMESCO Finland

Intravenous

2.9

307.7

3686

6915

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.1

307.7

2737

4861

Z3229

NOMESCO Finland

Other healthcare associate professional

2.9

307.7

3224

6080

M79.6

ICD-10 Finland

Pain in limb

2.0

307.7

16627

53450

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

5.0

307.7

5385

6169

UJF30

NOMESCO Finland

Ileoscopy through colon

2.5

307.7

3026

6690

WX290

NOMESCO Finland

Other blockage of nerve

1.6

307.7

18995

73721

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

248.5

307.7

17303

594

N06BA04

ATC

methylphenidate; oral

4.2

307.7

1655

2123

N30.0

ICD-10 Finland

Acute cystitis

2.1

307.7

5883

15977

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

307.7

8929

28433

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

91.8

307.7

1839

109

Z00.8

ICD-10 Finland

Other general examinations

11.2

307.7

7997

4440

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

10193

27026

SPAT1312

SPAT

General health counselling

1.7

307.7

12911

43985

J01DB01

ATC

cefalexin; oral

2.1

307.7

35086

148543

F99

ICD-10 Finland

Mental disorder, not otherwise specified

5.5

307.7

1031

1005

R1250

NOMESCO Finland

Evaluation of functional capability

6.1

307.7

1184

1040

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.5

307.7

3330

7342

R05

ICPC

Cough

1.9

307.7

8935

27132

R03AC02

ATC

salbutamol; inhalant

1.8

307.7

21981

81276

F51.0

ICD-10 Finland

Nonorganic insomnia

2.2

307.7

6701

17339

DAX08

NOMESCO Finland

Fitting of hearing aid

3.4

307.7

1540

2455

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

13.5

307.7

545

213

M01AC06

ATC

meloxicam; systemic, rectal

1.6

307.7

12420

45838

H13

ICPC

Plugged feeling ear

1.9

307.7

6732

19742

C07AA05

ATC

propranolol; systemic

2.2

307.7

8395

22335

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.2

307.7

7747

11168

M79.7

ICD-10 Finland

Fibromyalgia

4.6

307.7

1311

1519

IGY02

NOMESCO Finland

Psychiatric monitoring contact

5.6

307.7

1621

1554

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.9

307.7

5176

10042

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

307.7

9578

28091

R83

ICPC

Respiratory infection other

1.7

307.7

10582

35860

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

307.7

3267

7648

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

307.7

16140

57555

XG474

NOMESCO Finland

Exhalation nntrogen oxide

5.4

307.7

1073

1055

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

9.5

307.7

8308

5492

F31.8

ICD-10 Finland

Other bipolar affective disorders

7.0

307.7

1073

815

S18

ICPC

Laceration/cut

2.1

307.7

18394

57982

S29

ICPC

Skin symptom/complaint other

1.8

307.7

6606

20015

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

5.5

307.7

1512

1479

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

307.7

19403

69370

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

35.4

307.7

1464

223

J01EA01

ATC

trimethoprim; systemic

1.8

307.7

8911

29033

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

307.7

2624

4733

L28

ICPC

Limited function/disability (L)

2.5

307.7

6574

15061

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.4

307.7

2347

3777

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.0

307.7

5155

13989

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.5

307.7

3799

8251

F90.0

ICD-10 Finland

Disturbance of activity and attention

4.1

307.7

1879

2452

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

46.9

307.7

1495

172

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

4.3

307.7

1280

1603

A02BC05

ATC

esomeprazole; systemic

1.8

307.7

14970

51001

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.8

307.7

2217

3139

N05AX08

ATC

risperidone; systemic

3.0

307.7

3980

7422

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

307.7

9085

29168

N03AX09

ATC

lamotrigine; oral

5.5

307.7

2746

2749

P03

ICPC

Feeling depressed

3.0

307.7

4962

9366

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.0

307.7

3386

6292

SPAT1310

SPAT

Counselling related to known health issue

2.2

307.7

14116

40094

N06AA09

ATC

amitriptyline; systemic

2.9

307.7

3637

6804

H03AA01

ATC

levothyroxine sodium; systemic

1.7

307.7

7641

24924

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

5.7

307.7

868

807

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.5

307.7

2978

6467

T36

ICD-10 Finland

Poisoning by systemic antibiotics

6.1

307.7

2641

2392

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

5.2

307.7

2241

2328

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

307.7

8824

28090

Z71.8

ICD-10 Finland

Other specified counselling

2.7

307.7

15158

36933

D19

ICPC

Teeth/gum symptom/complaint

1.7

307.7

10787

37606

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.8

307.7

1061

1171

N06AX05

ATC

trazodone; oral

4.6

307.7

1137

1305

A10AB05

ATC

insulin aspart; parenteral

2.7

307.7

2682

5374

ZY010

NOMESCO Finland

Hospital outpatient

5.0

307.7

3051

3353

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

42.0

307.7

815

103

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.8

307.7

2860

5627

N02BF02

ATC

pregabalin; oral

2.9

307.7

2118

3915

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

4.8

307.7

1076

1196

N05AN01

ATC

lithium; oral

5.0

307.7

1233

1307

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

6.3

307.7

994

834

P99

ICPC

Psychological disorders other

5.3

307.7

1691

1705

PLAK1, ,

NOMESCO Finland

10.6

307.7

779

390

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

6.9

307.7

1339

1046

R11

ICD-10 Finland

Nausea and vomiting

2.6

307.7

3359

6953

J02AC01

ATC

fluconazole; systemic

1.6

307.7

13745

49734

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

25.6

307.7

960

200

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.2

307.7

3286

5694

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

11.1

307.7

4492

2328

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

307.7

5462

14442

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

307.7

6018

14804

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

307.7

11395

36638

RF120, ,

NOMESCO Finland

9.2

307.7

651

374

R03DC03

ATC

montelukast; oral

1.9

307.7

5720

16911

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

307.7

2356

4590

Z01.1

ICD-10 Finland

Examination of ears and hearing

9.0

307.7

5606

3678

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

6.3

307.7

1768

1521

Z51.0

ICD-10 Finland

Radiotherapy session

8.6

307.7

750

463

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

307.7

16015

43989

SPAT1240

SPAT

Therapeutic discussion

3.2

307.7

5713

10190

N05AX12

ATC

aripiprazole; systemic

5.0

307.7

2467

2671

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

6.9

307.7

778

601

R53

ICD-10 Finland

Malaise and fatigue

2.2

307.7

9996

26882

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

6.9

307.7

947

728

SPAT1131

SPAT

Colonoscopy

4.6

307.7

1633

1887

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

307.7

19908

78443

SPAT1301

SPAT

No procedures

2.2

307.7

13730

38634

IGY99

NOMESCO Finland

Other psychiatric treatment contact

6.1

307.7

1192

1036

A29

ICPC

General symptom/complaint other

2.2

307.7

4318

10926

SAA03

NOMESCO Finland

Extended examination of mouth

1.8

307.7

15836

54382

R52.2

ICD-10 Finland

Other chronic pain

4.9

307.7

1618

1773

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

6.7

307.7

998

797

P01

ICPC

Feeling anxious/nervous/tense

2.6

307.7

5939

12758

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

7.1

307.7

745

555

N05AH04

ATC

quetiapine; oral

3.8

307.7

10358

17113

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

307.7

3119

7032

SFA20

NOMESCO Finland

Two-surface restoration

1.6

307.7

23447

94478

J01MA02

ATC

ciprofloxacin; systemic

1.7

307.7

14254

50090

RF420, ,

NOMESCO Finland

12.4

307.7

954

408

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

6.0

307.7

1033

915

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

12.5

307.7

5293

2474

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

307.7

27748

113698

Z08

ICPC

Social welfare problem

7.7

307.7

722

497

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

6.0

307.7

1982

1790

UKC02

NOMESCO Finland

Cystoscopy

2.2

307.7

5651

14484

R42

ICD-10 Finland

Dizziness and giddiness

2.3

307.7

8741

22478

E0000UV, ,

ATC

1.6

307.7

15788

58104

N06AX11

ATC

mirtazapine; oral

2.6

307.7

15772

40484

R60.0

ICD-10 Finland

Localized oedema

2.1

307.7

4103

10544

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.5

307.7

2324

2833

R07.3

ICD-10 Finland

Other chest pain

2.3

307.7

3557

8358

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

5.7

307.7

2793

2696

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.6

307.7

1618

1315

R02

ICPC

Shortness of breath/dyspnoea

2.3

307.7

4577

11202

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.3

307.7

1160

1427

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

7.0

307.7

730

551

SPAT1252

SPAT

Overall medication plan or its review

5.8

307.7

4018

3918

Z01.2

ICD-10 Finland

Dental examination

1.6

307.7

17458

66968

N03AX16

ATC

[U] pregabalin

2.6

307.7

9543

21947

Z2445

NOMESCO Finland

Psychologist

4.6

307.7

2056

2398

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

25.8

307.7

2361

503

M54.2

ICD-10 Finland

Cervicalgia

2.4

307.6

2765

6367

R55

ICD-10 Finland

Syncope and collapse

2.1

307.6

3761

9864

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

306.9

2482

5437

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

306.0

3323

8309

AN2

Balloon angioplasty, including several vessels

3.9

305.8

1168

1609

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

301.6

3139

7709

F41.00

ICD-10 Finland

Moderate panic disorder

5.6

299.7

757

712

R4110, ,

SPAT

2.3

299.6

2823

6639

A05

ICPC

Feeling ill

2.4

299.3

2461

5433

R01AD09

ATC

mometasone; nasal

1.5

298.6

16501

65796

PLAK0, ,

NOMESCO Finland

8.8

298.0

535

322

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.3

297.9

1444

2362

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

297.8

4469

12632

R35

ICD-10 Finland

Polyuria

2.5

296.2

2258

4801

R00.2

ICD-10 Finland

Palpitations

2.3

294.1

2664

6153

SPAT1255

SPAT

Intravenous administration of medicine

2.4

293.6

2406

5301

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

293.5

3611

9485

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

292.8

2530

5717

R03BA01

ATC

beclometasone; inhalant

1.9

292.3

4869

14254

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

292.1

7966

26969

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.1

292.0

3329

8485

R74

ICPC

Upper respiratory infection acute

1.5

291.7

12043

45068

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

7.5

291.5

579

405

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

290.9

6753

21879

M54.6

ICD-10 Finland

Pain in thoracic spine

2.3

290.5

2652

6146

L13

ICPC

Hip symptom/complaint

1.8

290.0

5483

16714

ZYC03

NOMESCO Finland

Remote contact, text-based

11.7

289.8

442

199

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.9

289.7

1716

3181

A98

ICPC

Health maint/preventive medicine

2.1

289.6

41464

202326

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.7

287.6

1978

3986

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

2.1

287.5

3424

8878

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

286.1

7479

25021

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.2

285.5

782

801

A02BC01

ATC

omeprazole; systemic

1.6

285.5

9295

32886

H01

ICPC

Ear pain/earache

2.0

284.3

4148

11599

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.8

283.7

1111

1560

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

283.6

13796

53421

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.7

283.4

704

650

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.5

283.1

893

1047

B01AB05

ATC

enoxaparin; parenteral

1.6

283.0

10069

36374

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

282.7

8262

28446

A02BA02

ATC

ranitidine; systemic

1.8

282.7

6061

19178

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.3

281.6

951

1184

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

279.5

6466

20904

F43.00

ICD-10 Finland

Acute stress reaction mild

3.8

278.9

1069

1476

P20

ICPC

Memory disturbance

2.0

278.8

3765

10234

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

4.3

278.6

919

1121

EB1VA, ,

NOMESCO Finland

1.9

277.5

4524

13135

M01AH05

ATC

etoricoxib; oral

1.4

277.2

22740

97454

Z11

ICPC

Compliance/being ill problem

12.9

277.2

403

164

SPAT1053

SPAT

Memory test

1.9

276.9

4203

11910

TAB00

NOMESCO Finland

Lumbar puncture

3.0

276.7

1521

2695

SPAT1262

SPAT

Handing over of treatment supplies

1.8

275.7

5808

18271

R01AD01

ATC

beclometasone; nasal

1.8

275.3

5405

16648

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

272.9

20114

84376

D11

ICPC

Diarrhoea

1.9

272.4

4199

11958

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.5

271.4

867

1028

F32.8

ICD-10 Finland

Other depressive episodes

5.1

271.4

749

773

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

268.5

3144

8089

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

268.5

3588

9710

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

268.4

8474

29693

D07AC01

ATC

betamethasone; topical

1.5

268.2

12567

48153

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

267.2

3804

10532

IHZ05

NOMESCO Finland

Therapeutic conversation

33.0

266.3

289

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.0

266.1

3558

9629

SPAT1058

SPAT

PEF monitoring instruction

2.2

264.6

2710

6598

J01MA14

ATC

moxifloxacin; systemic

2.1

264.3

2987

7575

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

264.3

4828

14530

SPAT1211

SPAT

Application of soft bandage

2.1

263.4

3067

7871

Z03

ICPC

Housing/neighbourhood problem

10.7

262.2

418

205

B01AC04

ATC

clopidogrel; oral

1.8

261.5

4821

14547

SFA00

NOMESCO Finland

Small restoration

1.8

261.3

4803

14479

P25

ICPC

Phase of life problem adult

2.8

260.6

1678

3259

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

259.5

2161

4792

N03AX11

ATC

topiramate; oral

4.0

259.5

951

1267

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

259.3

9652

35120

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

257.8

5240

16286

N01

ICPC

Headache

1.9

255.9

4020

11510

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.7

254.8

772

872

M01AX17

ATC

nimesulide; oral

1.6

254.6

7554

26023

H02AB04

ATC

methylprednisolone; systemic

1.8

254.4

4599

13784

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

254.0

6684

22326

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.0

253.6

3545

9743

J01FA10

ATC

azithromycin; systemic

1.4

253.5

21814

93659

L12

ICPC

Hand/finger symptom/complaint

1.7

253.2

5431

17142

T74.1

ICD-10 Finland

Physical abuse

4.2

253.1

860

1076

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.2

253.0

1290

2179

H02

ICPC

Hearing complaint

1.9

252.7

4023

11568

RF210, ,

NOMESCO Finland

3.4

252.7

1125

1735

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

252.4

4023

11572

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.9

252.1

1468

2691

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.5

251.1

1880

3955

SGA01

NOMESCO Finland

Emergency treatment

1.7

251.1

6180

20270

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.6

250.1

771

885

A10AB04

ATC

insulin lispro; parenteral

3.7

249.8

1017

1470

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.1

249.7

3077

8068

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

249.3

6678

22399

N03AF01

ATC

carbamazepine; oral, rectal

2.6

249.2

1774

3636

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

4.8

248.7

741

824

E66.8

ICD-10 Finland

Other obesity

2.5

248.6

1915

4086

XCK10

NOMESCO Finland

Photography of fundus of eye

2.3

248.4

2324

5436

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

13.9

247.0

348

132

M01AH01

ATC

celecoxib; oral

1.7

245.4

5673

18278

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.5

245.2

9942

36798

127

Kela drug reimbursment

Transplant complication

5.9

244.1

591

530

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

244.0

2551

6259

R29

ICPC

Respiratory symptom/complaint other

2.3

243.9

2238

5188

C08CA13

ATC

lercanidipine; oral

1.8

243.8

4383

13104

SPAT1043

SPAT

Audiometry

2.0

243.3

3082

8163

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.7

243.3

1582

3088

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

242.9

37261

177833

L02

ICPC

Back symptom/complaint

2.0

242.8

3479

9640

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

6.4

242.6

548

453

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

242.5

3839

11010

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

242.3

3903

11259

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.4

241.9

2116

4799

N06AG02

ATC

moclobemide; oral

2.8

241.9

1523

2920

C10AA01

ATC

simvastatin; oral

1.5

240.1

12893

50538

A10AE05

ATC

insulin detemir; parenteral

2.6

240.1

1673

3390

N06AA12

ATC

doxepin; systemic

2.6

239.2

1698

3474

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

239.1

2092

4744

R07

ICPC

Sneezing/nasal congestion

2.2

238.1

2556

6339

N05AH02

ATC

clozapine; systemic

4.0

237.8

872

1162

L29

ICPC

Musculoskeletal sympt/complt other

2.1

236.4

2743

7020

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

236.0

12570

49157

WZC30, ,

SPAT

2.3

235.8

2132

4908

J01CA08

ATC

pivmecillinam; oral

1.5

235.7

13139

51836

U01

ICPC

Dysuria/painful urination

2.2

235.4

2540

6312

U04

ICPC

Incontinence urine

2.6

235.3

1649

3351

SCA01

NOMESCO Finland

Preventive oral health care, short

1.5

234.5

11101

42387

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

4.3

234.5

776

949

J01FA06

ATC

roxithromycin; oral

1.4

234.2

13732

54689

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.5

233.4

1776

3765

Y96.9

ICD-10 Finland

Unspecified type of accident

4.6

233.0

720

828

K07.60

ICD-10 Finland

Snapping jaw

2.5

232.1

1744

3673

N04BC05

ATC

pramipexole; oral

2.2

231.3

2321

5594

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

229.9

2135

4973

J01MA12

ATC

levofloxacin; systemic

1.7

229.3

5843

19303

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.9

229.1

3687

10623

F40.1

ICD-10 Finland

Social phobias

3.3

227.5

1097

1786

F10.24

ICD-10 Finland

Alcohol depence active use

4.6

227.1

704

812

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.3

226.7

392

222

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

226.3

1736

3694

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

6.1

226.1

530

458

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

226.0

1617

3321

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

8.0

225.7

428

280

R03BA05

ATC

fluticasone; inhalant

1.6

225.1

6125

20576

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

224.8

5092

16283

G04BD12

ATC

mirabegron; oral

1.9

224.2

3329

9330

N03AF02

ATC

oxcarbazepine; oral

3.1

223.8

1197

2083

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

7.4

223.3

447

316

P72

ICPC

Schizophrenia

3.8

222.9

871

1220

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

222.1

7656

27236

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

222.0

2444

6120

K04.08

ICD-10 Finland

Other specified pulpit

2.0

221.6

2833

7521

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

5.0

221.1

620

650

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

220.0

26924

121509

IBA03

NOMESCO Finland

Psychotherapy evaluation

6.7

219.3

478

378

T78.4

ICD-10 Finland

Allergy, unspecified

2.7

219.2

1492

2984

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.4

219.0

492

404

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

10.9

218.9

346

167

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

6.5

217.5

483

391

XQ848

NOMESCO Finland

Dermatological photography

3.3

217.2

1050

1712

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.5

217.1

10747

41286

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

216.6

9796

36949

K08.80

ICD-10 Finland

Toothache NOS

2.0

216.4

3039

8347

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

4.5

216.2

686

808

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.3

216.0

1026

1653

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.7

215.1

5147

16695

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.5

215.0

8397

30694

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

214.6

2203

5357

SPAT1098

SPAT

Exercise ECG

4.0

214.5

782

1037

A10AB01

ATC

insulin (human); parenteral

3.1

214.3

1107

1884

A10AC01

ATC

insulin (human); parenteral

2.1

214.2

2377

5969

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.5

213.5

928

1406

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.8

213.4

840

1183

SPAT1251

SPAT

Organisation of medication

2.8

212.8

1300

2448

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

211.2

1747

3855

Z01.7

ICD-10 Finland

Laboratory examination

1.7

209.6

4550

14355

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

206.9

1538

3219

R03BA08

ATC

ciclesonide; inhalant

2.0

205.6

2666

7109

RD210, ,

NOMESCO Finland

4.4

204.8

670

811

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

204.8

6232

21482

R03BB04

ATC

tiotropium bromide; inhalant

1.9

204.4

3046

8536

-, ,

ICD-10 Finland

3.9

204.4

770

1048

SPAT1243

SPAT

Psychiatric/psychological examination

2.9

204.4

1180

2150

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

204.3

2342

5956

UJF92

NOMESCO Finland

Capsular endoscopy

4.4

203.8

657

785

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.1

203.6

2345

5974

R01AD08

ATC

fluticasone; nasal

1.5

203.0

9646

36669

R5110, ,

SPAT

2.3

202.1

1871

4348

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

22.2

202.0

241

K10.3

ICD-10 Finland

Alveolitis of jaws

2.4

201.6

1692

3758

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

201.4

1956

4642

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

200.9

18958

81424

L04AA06

ATC

mycophenolic acid; systemic

4.4

200.7

647

773

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.1

200.6

1025

1732

F32

ICD-10 Finland

Depressive episode

2.2

199.8

2025

4894

H04AA01

ATC

glucagon; nasal, parenteral

3.8

199.0

759

1043

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.1

198.8

1051

1815

Z50.1

ICD-10 Finland

Other physical therapy

2.5

198.4

1481

3106

E000001, ,

ATC

1.6

198.2

6751

23880

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.8

197.9

764

1060

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.3

197.7

1824

4231

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.8

197.0

1188

2220

RJ190, ,

NOMESCO Finland

51.9

196.5

198

R01AD12

ATC

fluticasone furoate; nasal

1.4

196.4

11093

43553

J05AB01

ATC

aciclovir; systemic

1.5

195.3

7010

25083

N17

ICPC

Vertigo/dizziness

1.8

195.1

3517

10486

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

194.8

2185

5506

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.9

194.7

3111

8922

S10

ICPC

Boil/carbuncle

2.2

194.6

1964

4738

D06

ICPC

Abdominal pain localized other

2.0

193.8

2731

7501

R06AX27

ATC

desloratadine; oral

1.5

192.2

9875

38054

M02AA10

ATC

ketoprofen; topical

1.6

191.6

5030

16684

K05

ICPC

Irregular heartbeat other

3.0

191.6

1048

1848

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

191.2

4495

14478

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

4.3

191.1

628

763

H02AB09

ATC

hydrocortisone; systemic

3.7

191.1

773

1111

A07AA02

ATC

nystatin; oral

2.3

190.9

1700

3880

S06

ICPC

Rash localized

2.2

190.5

1862

4429

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.7

190.3

472

435

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.6

190.1

798

1179

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

189.6

2711

7482

K59.0

ICD-10 Finland

Constipation

2.3

189.4

1786

4182

S22.3

ICD-10 Finland

Fracture of rib

2.1

189.2

2330

6088

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.6

188.8

1360

2800

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

188.0

3083

8913

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

187.9

9565

36766

XX1AD

NOMESCO Finland

Other CT-examination

7.6

187.9

369

254

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

187.6

7902

29240

R12

ICD-10 Finland

Heartburn

2.0

186.5

2594

7089

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.1

185.9

2072

5206

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

185.7

2304

6036

SPAT1285

SPAT

Provision of consultation response

2.3

184.8

1708

3963

R01AD58

ATC

fluticasone, combinations; nasal

1.5

184.8

8330

31245

R31

ICD-10 Finland

Unspecified haematuria

1.8

184.7

3131

9149

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.8

184.1

1151

2195

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

183.7

4871

16187

P18

ICPC

Medication abuse

8.4

183.6

337

210

G04BD08

ATC

solifenacin; oral

2.2

183.5

1867

4517

S04

ICPC

Lump/swelling localized

1.8

182.8

3359

10065

R33

ICD-10 Finland

Retention of urine

2.0

182.7

2464

6658

RJ410, ,

NOMESCO Finland

17.0

182.6

237

Z00.5

ICD-10 Finland

Examination of potential donor of organ and tissue

83.3

182.5

175

Z71.9

ICD-10 Finland

Counselling, unspecified

2.0

182.4

2283

6000

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.0

182.2

434

382

R52.1

ICD-10 Finland

Chronic intractable pain

7.1

181.6

377

280

RS221, ,

NOMESCO Finland

4.5

181.4

577

681

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

181.4

3575

10941

F43.29

ICD-10 Finland

Adaptation disorder UNS

3.2

180.8

881

1443

WX308

NOMESCO Finland

Sacral anesthesy

16.7

180.6

236

C01CA24

ATC

epinephrine; parenteral

2.2

180.0

1885

4615

R09

ICPC

Sinus symptom/complaint

1.9

180.0

2643

7359

N76.0

ICD-10 Finland

Acute vaginitis

2.1

179.6

1983

4962

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.7

179.3

1185

2330

H29

ICPC

Ear symptom/complaint other

1.8

178.9

3396

10275

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.2

178.9

878

1445

A10BA02

ATC

metformin; oral

1.5

178.7

8629

32782

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.4

178.4

821

1294

P27

ICPC

Fear of mental disorder

4.6

178.2

551

634

J46

ICD-10 Finland

Status asthmaticus

3.1

177.6

902

1518

R06.5

ICD-10 Finland

Mouth breathing

1.9

177.4

2886

8316

C08CA01

ATC

amlodipine; oral

1.4

177.4

11623

46701

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.4

177.4

786

1207

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.6

177.3

1227

2473

B01AA03

ATC

warfarin; systemic

1.6

176.2

5673

19755

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

176.1

6315

22537

R01AD11

ATC

triamcinolone; nasal

1.9

175.8

2698

7624

AA400

NOMESCO Finland

Electroconvulsive therapy

6.4

175.7

394

323

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

6.3

175.7

400

334

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

6.2

174.0

399

336

-42

ICPC

Electrical tracing

5.4

173.6

456

447

M01AB05

ATC

diclofenac; systemic, rectal

1.3

173.5

24246

109633

S80.0

ICD-10 Finland

Contusion of knee

2.0

173.3

2441

6696

L11

ICPC

Wrist symptom/complaint

1.9

172.9

2798

8046

L14

ICPC

Leg/thigh symptom/complaint

2.0

172.8

2369

6436

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

172.8

9689

37831

L04AX01

ATC

azathioprine; systemic

2.5

172.7

1347

2885

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.9

172.6

998

1819

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

172.6

3885

12345

SPAT1236

SPAT

Informing family of child’s disability

3.6

172.5

722

1064

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

171.8

1644

3872

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

5.9

171.7

411

364

R4190

NOMESCO Finland

Nutritional therapy

2.5

171.6

1272

2656

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

171.5

6638

24076

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.2

171.2

1811

4451

A10AE06

ATC

insulin degludec; parenteral

2.9

170.9

1020

1894

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

11.2

170.4

265

124

D07AC13

ATC

mometasone; topical

1.4

170.2

9606

37534

R03AK08

ATC

formoterol and beclometasone; inhalant

2.5

169.9

1347

2908

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

5.2

169.3

458

463

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

4.2

169.2

575

719

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.0

169.0

2262

6091

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

168.9

3362

10311

XF402

NOMESCO Finland

ECG with work load test

1.9

168.7

2570

7241

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

168.4

4925

16746

D10

ICPC

Vomiting

2.0

167.9

2155

5713

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

167.7

1954

4993

XG466

NOMESCO Finland

Sleep oxymetry

2.9

167.4

946

1701

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

167.2

2351

6442

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

165.9

4258

14007

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.5

165.7

718

1085

F33.8

ICD-10 Finland

Other recurrent depressive disorders

5.9

165.7

397

352

RJ421, ,

NOMESCO Finland

15.3

165.6

224

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

165.0

2536

7166

C09CA06

ATC

candesartan; oral

1.5

164.8

7483

28024

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.3

164.8

1451

3292

F03

ICPC

Eye discharge

2.0

163.8

2147

5735

JAH01

NOMESCO Finland

Laparoscopy

2.4

163.7

1356

2990

C10AA07

ATC

rosuvastatin; oral

1.4

163.6

9543

37468

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

163.4

2875

8488

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

163.4

2647

7611

P19

ICPC

Drug abuse

5.2

163.3

440

443

K03.66

ICD-10 Finland

Tooth plaque

1.9

162.9

2316

6370

K05.30

ICD-10 Finland

Periodontitis complex

1.6

162.7

4456

14899

U05

ICPC

Urination problems other

2.3

162.2

1477

3402

K29

ICPC

Cardiovascular sympt/complt other

2.5

162.1

1208

2529

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

161.6

3399

10586

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

6.4

161.5

365

302

Z06

ICPC

Unemployment problem

5.8

161.3

394

357

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.6

161.3

1136

2310

ZX112

NOMESCO Finland

Subcutaneous

3.4

161.1

712

1091

H36.00

ICD-10 Finland

Diabetic background retinopathy

5.1

160.9

443

456

F22.0

ICD-10 Finland

Delusional disorder

3.9

160.1

602

818

ZY000

NOMESCO Finland

Hospital inpatient

4.1

160.1

558

713

RJ411, ,

NOMESCO Finland

10.8

159.5

253

123

B01AF01

ATC

rivaroxaban; oral

1.7

159.5

3526

11135

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.5

158.9

1240

2656

A02BC04

ATC

rabeprazole; oral

1.9

158.8

2512

7164

N04AA02

ATC

biperiden; systemic

3.3

158.7

743

1185

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.9

158.5

599

817

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.9

158.4

303

201

SXC05

NOMESCO Finland

Other oral or dental procedure

1.9

158.3

2270

6261

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

4.0

158.0

577

766

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.3

157.4

1440

3323

K04.09

ICD-10 Finland

Pulpit UNS

2.2

157.4

1610

3900

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

157.3

3910

12744

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

156.8

6785

25136

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

156.7

2012

5332

G04CA02

ATC

tamsulosin; oral

1.5

156.6

7271

27319

N05AE04

ATC

ziprasidone; systemic

6.9

156.5

331

252

F60.5

ICD-10 Finland

Anankastic personality disorder

4.7

156.4

466

518

SPAT1106

SPAT

Acupuncture

7.1

156.2

322

237

R07.0

ICD-10 Finland

Pain in throat

1.9

155.8

2342

6565

F31

ICD-10 Finland

Bipolar affective disorder

4.2

155.6

526

655

R06.4

ICD-10 Finland

Hyperventilation

4.0

155.5

560

735

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

268.1

155.3

205

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

4.7

155.2

461

511

J01DA09

ATC

[U] cefadroxil

1.4

155.2

9020

35337

P28

ICPC

Limited function/disability (P)

5.6

155.1

390

365

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.4

154.9

1291

2854

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

154.7

3046

9302

R06AX22

ATC

ebastine; oral

1.5

154.5

5397

19100

K08.3

ICD-10 Finland

Retained dental root

1.9

154.0

2472

7082

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.3

153.4

503

610

F43.01

ICD-10 Finland

Acute stress reaction moderate

3.7

153.4

621

893

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

153.3

1304

2910

W19

ICD-10 Finland

Unspecified fall

1.7

153.2

3104

9558

C10AA05

ATC

atorvastatin; oral

1.4

153.0

12439

51527

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

2.0

152.7

2042

5492

K90

ICPC

Stroke/cerebrovascular accident

3.0

152.6

833

1466

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

152.6

1225

2660

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

8.0

152.5

289

189

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.2

152.2

1565

3799

F93.89

ICD-10 Finland

Other childhood emotional disorders

6.9

152.1

320

242

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

10.8

152.1

241

117

S21

ICPC

Skin texture symptom/complaint

1.6

151.8

4298

14474

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.5

151.7

1151

2431

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.2

151.6

1600

3926

UJD02

NOMESCO Finland

Gastroscopy

2.4

151.1

1301

2920

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

151.1

3138

9730

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.2

151.1

1530

3690

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

7.2

151.0

310

227

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

9.6

150.9

255

139

SDA03

NOMESCO Finland

Periodontal treatment

1.3

150.7

13843

58402

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

150.6

3884

12774

Z01.9

ICD-10 Finland

Special examination, unspecified

2.3

150.6

1445

3405

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.7

150.6

971

1883

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

150.5

2050

5550

D02

ICPC

Abdominal pain epigastric

2.1

150.1

1741

4437

S97

ICPC

Chronic ulcer skin

2.1

149.5

1644

4102

ACC51

NOMESCO Finland

Release of median nerve

1.9

149.5

2166

5993

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.6

149.4

459

525

C09CA01

ATC

losartan; oral

1.4

149.2

7686

29426

Z72.2

ICD-10 Finland

Drug use

8.4

148.9

273

170

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

148.8

5136

18114

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

148.8

1400

3271

IGV01

NOMESCO Finland

Psychiatric network contact

4.8

148.5

436

478

M54.8

ICD-10 Finland

Other dorsalgia

2.3

148.4

1392

3248

C10AC01

ATC

colestyramine; oral

3.0

148.3

799

1395

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.3

148.3

394

391

G54.0

ICD-10 Finland

Brachial plexus disorders

2.9

148.2

845

1527

C05AA08

ATC

fluocortolone; rectal, topical

1.6

148.1

4129

13848

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

147.6

2445

7075

D09

ICPC

Nausea

2.2

147.5

1540

3761

N05AD01

ATC

haloperidol; systemic

2.5

147.2

1135

2416

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

147.2

931

1786

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.8

147.2

428

465

SPAT1370

SPAT

Other health check-up

2.3

147.2

1369

3182

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

18.9

147.0

184

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.2

146.9

1501

3633

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

3.0

146.7

820

1464

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3017143) Hepatitis C virus Ab [Presence] in Serum

6105

18762

1.81

316.82

1.8

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5789

17584

1.83

311.43

3.1

2.2

22.52

23.44

4.53

5056

15016

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4979

14446

1.90

308.07

4.9

3.9

239.69

246.45

u/l

2.07

4670

13718

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6337

16484

2.17

307.65

7.8

4.7

1.05

1.03

mmol/l

5.09

5977

15323

(3048689) Calprotectin [Mass/mass] in Stool

5972

16853

1.98

307.65

2.4

2.5

142.02

140.16

ug/g

0.10

4693

13466

(1001926) Buprenorphine [Presence] in Urine by Screen method

2839

5597

2.76

307.65

3.2

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

13549

43323

1.91

307.65

3.6

2.9

7.84

8.10

mmol/l

6.30

11945

36741

(3010813) Leukocytes [#/volume] in Blood

41766

201683

2.37

307.65

26.1

15.1

6.84

6.69

e9/l

24.72

41173

194145

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

31485

117586

2.37

307.65

8.8

6.4

77.73

78.00

u/l

0.38

30208

109977

(3001122) Ferritin [Mass/volume] in Serum or Plasma

18793

68506

1.75

307.65

3.3

2.5

119.31

121.53

ug/l

0.49

17674

63636

(3022948) Iron [Moles/volume] in Serum or Plasma

7058

20455

1.95

307.65

2.9

2.1

13.29

13.52

umol/l

1.59

6601

18952

(3029937) Albumin [Presence] in Urine by Test strip

12972

43649

1.78

307.65

4.7

3.2

0.00

estimate

6.28

5421

15442

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

19358

73304

1.67

307.65

2.9

2.3

—

(3028707) Methadone [Presence] in Urine by Screen method

2347

2066

6.20

307.65

3.5

2.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

5157

10518

2.76

307.65

4.7

3.5

0.66

0.68

0.18

1652

3021

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6371

14331

2.54

307.65

8.6

5.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

18312

61742

1.93

307.65

7.5

5.3

1.21

mmol/l

0.38

16873

56369

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

35515

162536

1.70

307.65

4.2

3.4

1.35

1.28

mmol/l

44.56

33281

150281

(3020779) Urea [Moles/volume] in Serum or Plasma

4517

11084

2.25

307.65

10.3

5.8

9.14

9.62

mmol/l

3.98

4351

10517

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

38729

172369

2.35

307.65

17.9

10.5

20.64

24.86

mg/l

108.22

32497

130706

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3508

8681

2.20

307.65

1.8

1.5

—

(3000850) Epithelial cells [#/volume] in Urine

9570

30808

1.79

307.65

3.1

2.3

5.42

6.03

e6/l

3.35

8983

27078

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

36597

170734

1.68

307.65

4.6

3.7

4.59

4.74

mmol/l

135.55

34395

159719

(3023103) Potassium [Moles/volume] in Serum or Plasma

39422

173104

2.68

307.65

19.6

12.1

3.97

3.96

mmol/l

20.90

38702

167282

(3013115) Eosinophils [#/volume] in Blood

22289

76476

2.05

307.65

7.4

5.2

0.19

e9/l

0.11

20402

65876

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3286

7857

2.28

307.65

9.1

6.5

24.74

24.45

mmol/l

3.61

3199

7414

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

36522

159550

2.10

307.65

14.6

10.4

84.56

84.68

ml/min/173m2

0.40

32407

127180

(3021960) Folate [Moles/volume] in Serum or Plasma

9867

29557

1.95

307.65

1.6

1.4

20.09

19.91

nmol/l

0.48

8605

25455

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3563

6763

2.90

307.65

4.7

3.0

1.46

1.94

mmol/l

10.35

2626

4898

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2921

4245

3.77

307.65

2.3

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

24376

87318

2.01

307.65

10.9

8.0

4.09

4.16

e9/l

3.87

22458

74245

(3013826) Glucose [Moles/volume] in Serum or Plasma

25217

87016

2.19

307.65

5.7

4.1

6.67

6.63

mmol/l

1.89

24038

79890

(3019060) Gas panel - Arterial blood

3364

8189

2.24

307.65

6.1

4.4

—

(3007461) Platelets [#/volume] in Blood

41743

201357

2.37

307.65

26.0

15.1

252.76

251.86

e9/l

1.91

41209

194540

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

27091

115766

1.57

307.65

4.0

2.5

49.99

44.95

u/l

12.59

25679

108899

(3019150) Specific gravity of Urine by Refractometry

10139

32452

1.82

307.65

4.7

3.2

1.02

kg/l

0.57

1570

4847

(3027944) Amphetamines [Presence] in Urine

3260

7755

2.29

307.65

2.9

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

7554

20767

2.08

307.65

2.2

1.6

1.52

1.37

48.45

6841

18455

(3017181) Myelocytes/100 leukocytes in Blood

5615

11398

2.80

307.65

4.9

3.6

0.95

0.99

0.33

1843

3583

(3018010) Neutrophils/100 leukocytes in Blood

20029

72195

1.82

307.65

7.0

5.0

56.89

57.14

2.00

19078

67698

(40761535) Cells panel - Urine sediment

4428

9128

2.70

307.65

4.1

2.8

—

(3000764) Benzodiazepines [Presence] in Urine

3379

7709

2.39

307.65

3.0

1.6

—

(3035941) MCH [Entitic mass]

41750

201620

2.36

307.65

25.9

15.1

30.24

30.22

1.45

41377

198283

(3006504) Eosinophils/100 leukocytes in Blood

19809

70016

1.86

307.65

7.2

5.2

2.86

2.82

1.51

18765

65402

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13442

50389

1.56

307.65

4.1

2.7

33.12

34.17

u/l

0.71

12874

47568

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7547

24300

1.75

307.65

1.3

1.2

39.32

37.21

iu/ml

0.16

2242

8004

(3011288) Drugs identified in Urine by Screen method

2617

4426

3.22

307.65

4.1

2.2

—

(3009261) Glucose [Presence] in Urine by Test strip

19818

80859

1.50

307.65

4.3

3.0

0.00

estimate

0.55

5450

15815

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5015

11169

2.51

307.65

2.3

2.2

360.54

382.33

nmol/l

9.15

4636

10394

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4867

9047

3.03

307.65

2.8

2.0

6.08

8.57

ug/l

8.26

4316

7911

(3016502) Oxygen saturation in Arterial blood

4834

12962

2.06

307.65

8.0

7.7

95.44

95.64

1.09

4706

12433

(3028300) Cannabinoids [Presence] in Urine

3384

7803

2.37

307.65

3.1

1.6

—

(3027008) Opiates [Presence] in Urine

3377

7779

2.37

307.65

3.0

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11779

34121

2.09

307.65

3.5

2.7

1429.63

1457.51

ng/l

0.22

10072

28847

(3026008) Bacteria identified in Urine by Culture

13090

41944

1.89

307.65

3.5

2.6

—

(3021589) Normoblasts [#/volume] in Blood

19574

72488

1.73

307.65

10.6

8.7

0.00

e9/l

0.48

17593

57697

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

36349

169448

1.66

307.65

4.6

3.7

1.42

1.45

mmol/l

35.98

34205

157677

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

17454

51986

2.24

307.65

4.1

3.0

50.00

61.79

ng/l

0.79

12386

32429

(3022096) Basophils/100 leukocytes in Blood

19183

67759

1.84

307.65

7.2

5.2

0.68

0.66

3.09

18140

63077

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

9899

32076

1.79

307.65

1.3

1.2

1.48

1.75

u/ml

1.39

3397

9243

(3024731) MCV [Entitic volume]

41759

201642

2.36

307.65

25.9

15.1

90.81

90.49

34.65

41379

198301

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9729

30732

1.83

307.65

2.1

1.6

1.05

1.25

mg/l

8.33

7249

23469

(3025159) Blasts/100 leukocytes in Blood

5042

10519

2.69

307.65

5.1

3.7

0.30

0.26

0.12

1273

2759

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3379

6881

2.69

307.65

1.6

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

8418

22751

2.15

307.65

1.8

1.7

1268.28

1209.01

nmol/l

5.70

6591

17022

(3024561) Albumin [Mass/volume] in Serum or Plasma

17619

60945

1.84

307.65

5.8

4.3

35.61

35.62

g/l

0.06

16561

56268

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

9836

30755

1.86

307.65

1.6

1.7

4415123.47

35221092.61

pmol/l

13.80

8585

25468

(3019225) pH of Specimen

5335

9916

3.05

307.65

5.0

3.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

15842

42630

2.46

307.65

3.2

2.3

58.52

65.56

u/l

1.60

14850

39197

(40768797) Stomach Pathology biopsy report

6083

16360

2.09

307.65

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

41683

201175

2.33

307.65

25.9

15.3

40.77

40.96

0.66

40073

188143

(40761511) CBC panel - Blood by Automated count

39041

184283

1.88

307.65

16.4

10.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11330

33234

2.05

307.65

2.5

2.0

3.03

2.89

mg/l

6.80

9939

28095

(3000963) Hemoglobin [Mass/volume] in Blood

41769

201773

2.36

307.65

26.1

15.2

135.70

137.11

g/l

66.16

41363

198497

(40760892) CBC W Ordered Manual Differential panel - Blood

20571

69913

2.00

307.65

7.4

5.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

30281

113959

2.22

307.65

4.7

3.2

11.37

11.22

mm/h

0.95

28549

105031

(3021440) Promyelocytes/100 leukocytes in Blood

5354

10931

2.77

307.65

5.0

3.6

0.11

0.13

0.67

1587

3128

(3042936) Bacteria identified in Isolate by Culture

6460

19218

1.88

307.65

2.3

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

35607

152971

2.09

307.65

5.3

3.9

2.06

2.18

mu/l

0.42

33493

140155

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7237

22653

1.80

307.65

1.3

1.2

9.89

11.57

u/ml

1.30

3421

9258

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

13887

38735

2.27

307.65

2.6

1.9

212.21

227.36

u/l

0.66

13248

36117

(3018405) Lactate [Moles/volume] in Arterial blood

2348

4356

2.91

307.65

5.0

4.0

1.41

1.44

mmol/l

0.50

2314

4288

(3019069) Monocytes/100 leukocytes in Blood

19935

70518

1.86

307.65

7.6

5.4

8.43

8.54

5.22

18922

65949

(3037522) Nuclear Ab [Titer] in Serum

6144

18519

1.85

307.65

1.4

1.3

559.35

531.66

titre

0.46

1298

3331

(3007164) IgA [Mass/volume] in Serum or Plasma

8623

27723

1.77

307.65

1.5

1.4

2.34

2.39

g/l

1.13

5847

17570

(3031040) Bacteria [#/volume] in Urine by Automated count

26713

102465

1.91

307.65

5.3

3.6

1365.37

1223.53

e6/l

0.12

243

2094

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

16457

63618

1.56

307.65

4.4

3.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2750

3910

3.85

307.65

2.1

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7729

20423

2.18

307.65

2.1

1.6

—

(3026361) Erythrocytes [#/volume] in Blood

41763

201676

2.36

307.65

26.0

15.1

4.51

4.56

e12/l

69.18

41145

194175

(3022313) Gas panel - Capillary blood

2768

4602

3.28

307.65

5.0

3.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

16062

53729

1.88

307.65

2.1

1.7

97.16

94.98

pmol/l

6.15

9070

27726

(3022217) INR in Platelet poor plasma by Coagulation assay

19684

64405

2.07

307.65

15.3

12.6

1.26

1.23

inr

2.90

7205

20513

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

31402

124172

2.09

307.65

4.4

3.5

14.71

14.66

pmol/l

2.49

29282

112310

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

22186

74063

2.13

307.65

7.2

5.5

10.58

11.96

umol/l

36.23

21121

69884

(3005719) IgG [Mass/volume] in Serum or Plasma

3716

9364

2.17

307.65

2.9

2.4

10.22

10.79

g/l

11.48

3469

8448

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5172

14623

1.96

307.65

7.8

7.3

5.11

5.08

kpa

1.41

4987

13895

(3037467) Urinalysis macro (dipstick) panel - Urine

27130

109314

1.76

307.65

5.0

3.4

—

(3023368) Bacteria identified in Blood by Culture

11908

37755

1.88

307.65

4.5

4.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

11782

41627

1.65

307.65

3.9

3.5

10.54

8.60

mg/mmol

3.31

8071

26124

(3021601) Nitrite [Presence] in Urine by Test strip

19666

80002

1.51

307.65

5.3

4.0

0.00

estimate

1.70

5578

16290

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5369

13977

2.14

307.65

4.7

3.8

31.69

31.71

0.05

3785

9660

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

36120

162794

1.85

307.65

4.7

3.8

5.95

5.81

mmol/l

59.74

33700

148940

(3019198) Lymphocytes [#/volume] in Blood

21970

77014

1.97

307.65

7.2

5.0

1.94

e9/l

0.11

20353

66930

(3020564) Creatinine [Moles/volume] in Serum or Plasma

40304

185583

2.45

307.65

19.5

12.1

79.02

76.16

umol/l

35.95

40282

185483

(3016879) Cocaine [Presence] in Urine

3201

7131

2.45

307.65

3.1

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

14105

47732

1.79

307.65

3.0

3.5

2.35

mmol/l

10.06

12529

42753

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3860

6997

3.06

307.65

4.7

3.0

5.14

kpa

0.23

3684

6646

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

21260

66928

2.26

307.65

8.5

5.4

1.21

mmol/l

0.82

19073

54071

(3013512) EKG study

11932

38305

1.86

307.65

4.2

3.3

—

(3036180) Methadone [Presence] in Urine

718

528

7.20

307.65

2.7

1.7

—

(3009343) pH of Capillary blood

3778

6937

3.01

307.65

4.7

3.0

7.41

7.42

0.74

274

1441

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

40088

187073

2.22

307.65

12.2

8.0

27.31

27.04

u/l

1.30

39107

180005

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2223

3915

3.07

307.65

5.5

3.2

24.64

24.83

mmol/l

1.89

2076

3631

(3019550) Sodium [Moles/volume] in Serum or Plasma

39342

172385

2.68

307.65

19.7

12.0

139.48

139.68

mmol/l

43.41

38680

166974

(3027801) Oxygen [Partial pressure] in Arterial blood

5170

14612

1.96

307.65

7.8

7.3

12.07

12.64

kpa

9.81

4981

13879

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

6412

19656

1.82

307.65

2.3

1.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

18018

57665

2.06

307.65

2.6

2.0

75.72

75.52

nmol/l

0.37

16576

52177

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7156

21869

1.84

307.65

4.5

3.1

0.82

mmol/l

1.96

6784

20465

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6377

18862

1.89

307.65

2.9

2.1

2.39

2.33

g/l

9.85

5923

17254

(3012516) Albumin [Mass/volume] in Urine

11436

39378

1.69

307.65

3.4

3.0

532.94

331.32

mg/l

3.77

8160

24962

(3007853) Bacteria identified in Skin by Aerobe culture

5834

15713

2.08

307.65

2.0

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

19634

79807

1.51

307.65

4.3

3.0

0.00

estimate

2.21

5744

16930

(3006315) Basophils [#/volume] in Blood

21663

73855

2.04

307.65

7.1

5.0

0.04

e9/l

2.27

19824

62196

(3009466) Valproate [Moles/volume] in Serum or Plasma

1390

1722

4.32

307.65

6.0

4.5

375.80

363.46

umol/l

1.81

1250

1467

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10274

34733

1.71

307.65

2.8

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

34337

151372

1.81

307.65

5.9

4.6

39.86

38.72

mmol/mol

78.67

32275

140328

(3002030) Lymphocytes/100 leukocytes in Blood

20296

73715

1.80

307.65

7.3

5.2

28.32

28.20

0.79

19300

69205

(3001604) Monocytes [#/volume] in Blood

21598

73727

2.03

307.65

7.1

5.0

0.58

0.59

e9/l

5.96

19779

62151

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4389

12242

1.97

304.02

2.7

2.0

0.21

0.22

g/l

1.31

4124

11362

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

36934

173801

1.65

300.44

4.8

4.1

2.72

2.84

mmol/l

109.59

34618

161397

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1033

1307

4.20

300.24

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

3707

9782

2.07

297.96

3.0

2.5

72.02

68.50

e9/l

5.92

3105

6926

(3043409) Potassium [Moles/volume] in Arterial blood

1914

3743

2.74

294.18

5.7

4.2

3.87

3.90

mmol/l

2.29

1907

3714

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6835

22160

1.72

293.98

2.3

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

697

616

5.98

291.68

1.6

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1367

2200

3.31

288.90

1.5

1.2

—

(3003396) Base excess in Arterial blood by calculation

4986

14778

1.86

287.94

8.0

7.2

1.41

0.90

mmol/l

15.42

3994

11849

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2886

6995

2.23

285.46

3.4

2.4

0.22

0.29

e6/l

2.43

2831

6777

(3012544) pH of Venous blood

4392

12524

1.92

284.55

5.0

3.3

7.37

7.38

0.82

120

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4262

12073

1.93

281.30

5.1

3.3

5.89

5.81

kpa

4.68

4134

11740

(3044889) 12 lead EKG panel

25743

112821

1.45

280.44

3.8

3.2

—

(40768804) Tissue Pathology biopsy report

15565

61894

1.48

280.39

2.1

1.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1446

2471

3.12

278.78

1.6

1.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

675

621

5.74

272.59

12.3

11.6

0.62

mmol/l

0.10

633

562

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

878

1051

4.43

271.93

1.6

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6362

20729

1.70

266.25

2.6

1.9

29.62

29.94

3.45

6169

20134

(3020891) Body temperature

2334

5304

2.37

266.21

6.5

4.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1670

3209

2.78

264.46

3.5

2.9

24.51

24.82

mmol/l

1.86

1634

3139

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

887

1099

4.28

264.07

1.6

1.3

—

(3002032) Base excess in Venous blood by calculation

4182

12014

1.90

264.00

5.3

3.3

2.01

1.78

mmol/l

3.21

3542

10263

(3000494) Fungus identified in Specimen by Culture

5149

15838

1.79

262.52

1.7

1.3

—

(3002582) Erythrocytes [#/volume] in Urine

11990

45682

1.51

261.46

3.9

2.7

80.91

110.62

e6/l

1.09

10206

33032

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3146

8189

2.08

260.53

4.5

3.4

97.00

87.72

ng/l

3.49

2745

7029

(3025468) Yersinia sp identified in Specimen by Organism specific culture

857

1048

4.33

259.01

1.6

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

857

1048

4.33

259.01

1.6

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

317

20.31

258.75

3.5

6.7

72.74

71.63

0.13

288

(3005988) Vibrio sp identified in Specimen by Organism specific culture

857

1050

4.32

258.44

1.6

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

857

1068

4.25

253.38

1.6

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

10570

39447

1.52

252.19

3.1

2.3

1482.08

5213.01

umol/l

31.83

9406

34866

(3044640) Blood type and Crossmatch panel - Blood

12399

47902

1.49

250.59

2.9

2.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

731

803

4.81

248.48

3.7

2.9

55.98

57.86

1.07

654

686

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4183

12326

1.85

243.45

8.8

7.9

123.04

122.69

g/l

0.44

4109

11951

(3018095) Leukocytes [#/volume] in Urine

13631

53964

1.46

241.63

4.5

3.1

104.87

99.12

e6/l

0.25

10992

35654

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1524

2970

2.74

234.97

1.4

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1504

2944

2.72

229.98

1.5

1.3

528.50

566.74

mg/l

0.43

1438

2817

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2052

4716

2.33

227.62

2.3

1.8

1.90

2.54

ug/l

1.63

1836

4204

(3005322) IgE [Units/volume] in Serum or Plasma

2965

7958

2.01

225.32

1.4

1.2

229.48

257.55

u/ml

0.62

2747

7346

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

668

745

4.73

223.43

1.8

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

668

745

4.73

223.43

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

668

745

4.73

223.43

1.8

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1348

2524

2.84

222.98

3.2

2.4

31.43

35.14

umol/l

7.17

1246

2266

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1366

2580

2.82

222.56

1.4

1.2

3.78

3.70

mmol/l

1.53

1288

2430

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1068

1735

3.27

222.15

1.4

1.3

25.94

25.65

u/l

0.08

881

1477

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1009

1586

3.37

220.33

1.9

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1009

1587

3.37

220.12

1.9

1.5

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

564

544

5.47

218.04

3.3

2.7

41918.78

42145.32

ug/l

0.08

564

544

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3172

8824

1.94

217.96

2.4

2.3

22.23

22.59

au/ml

0.06

214

832

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4626

14519

1.74

217.56

1.9

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4582

14363

1.74

216.34

1.9

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

3450

9918

1.88

215.20

4.5

2.7

4.80

4.56

kpa

6.64

3338

9598

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

315

134

12.35

212.29

1.4

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

4521

14208

1.74

211.27

3.1

2.4

1.83

1.70

13.22

4005

12604

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1487

3034

2.61

210.24

1.4

289.74

268.22

ug/g

2.82

848

1748

(3028026) IgM [Mass/volume] in Serum or Plasma

2753

7372

2.01

210.04

1.9

1.23

1.29

g/l

0.66

2540

6726

(40758558) Short blood count panel - Blood

9530

36027

1.48

206.81

7.9

6.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2914

8033

1.96

205.01

1.3

1.2

52.58

52.40

au/ml

0.01

128

478

(3022145) Colonoscopy Study observation

4730

15202

1.70

203.62

1.3

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2202

5482

2.15

202.44

4.1

3.4

49.13

48.06

0.94

2172

5425

(3020630) Protein [Mass/volume] in Serum or Plasma

3336

9692

1.86

200.95

2.6

2.3

66.21

66.50

g/l

1.23

3055

8879

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1644

3618

2.42

199.69

1.9

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1758

4001

2.35

198.75

2.5

2.2

470.34

630.67

ug/l

1.00

1630

3760

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

726

970

3.95

197.23

2.0

1.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

695

904

4.06

195.15

19.7

16.2

2376.35

3071.98

nmol/l

0.14

672

871

(3037121) Protein [Mass/volume] in Urine

1684

3792

2.37

194.77

3.4

0.38

0.31

g/l

1.32

770

1907

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

675

860

4.14

194.32

15.0

11.2

765.15

1998.29

nmol/l

0.54

651

826

(46235355) HIV 1 and 2 tests - Meaningful Use set

9158

34721

1.47

193.94

2.1

1.8

—

(3026782) Osmolality of Urine

8182

30336

1.50

193.19

3.4

2.5

515.18

555.51

mosm/kgh2o

47.20

7401

25769

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3392

10052

1.82

191.69

2.8

2.2

67.15

69.24

ml/min/173m2

1.83

1405

4009

(3027273) Bicarbonate [Moles/volume] in Venous blood

2317

6057

2.05

187.89

4.4

2.9

25.09

25.25

mmol/l

1.27

2257

5857

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2016

5043

2.14

182.79

1.3

1.2

0.92

0.64

u/ml

0.52

185

497

(3029634) Reagin Ab [Titer] in Serum by VDRL

941

1599

3.12

182.50

1.9

1.7

6.71

3.29

titre

0.45

(3014111) Lactate [Moles/volume] in Serum or Plasma

3744

11616

1.74

181.36

7.3

7.1

1.45

1.35

mmol/l

4.08

3638

11318

(3017732) Neutrophils [#/volume] in Blood

3141

9267

1.83

179.54

3.3

2.5

5.66

4.84

e9/l

1.68

2418

7876

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2960

8572

1.86

179.28

3.1

3.5

4.47

4.55

pmol/l

3.09

2664

7742

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

658

878

3.95

179.03

2.0

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1307

2716

2.56

178.07

1.5

1.4

4201.49

965.54

e6/l

0.65

1142

2123

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1305

2714

2.55

177.51

1.4

24.17

32.10

e6/l

0.48

1105

1992

(3018418) pH of Serum or Plasma

10753

42650

1.42

176.45

4.7

3.6

7.39

7.40

36.67

2512

9806

(3045414) Leukocytes [Presence] in Urine

1941

4869

2.13

174.62

1.9

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

26572

121817

1.34

173.33

3.3

3.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1474

3297

2.38

172.68

4.9

2.9

8.57

8.31

kpa

5.59

1446

3222

(3030467) Casts [#/volume] in Urine by Automated count

10504

41649

1.41

171.83

3.6

2.7

0.32

0.47

e6/l

8.65

8902

29662

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6954

25489

1.50

170.86

4.4

3.1

371.21

604.20

ng/l

5.06

4593

19216

(4146454) Self-monitoring of blood glucose

496

539

4.84

170.48

2.9

1.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2409

6623

1.95

169.82

2.5

2.1

5962.69

6753.41

u/l

0.46

871

2704

(3020191) Ethanol [Moles/volume] in Serum or Plasma

699

1026

3.60

167.95

1.6

1.4

1.46

1.37

promille

0.64

491

762

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1286

2733

2.50

167.49

1.4

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

11600

47112

1.39

163.48

3.6

2.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

387

345

5.90

160.74

37.5

31.7

7.58

7.48

ug/l

0.26

345

317

(3004809) Band form neutrophils/100 leukocytes in Blood

970

1827

2.81

158.46

3.7

2.8

1.50

1.56

0.21

889

1632

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1885

4855

2.07

158.33

5.6

4.5

1.77

1.68

1.82

1776

4499

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2361

6618

1.91

157.07

1.8

1.5

—

(3025941) Bacteria identified in Stool by Culture

2871

8622

1.79

154.13

1.3

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

421

432

5.12

153.39

2.1

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

421

432

5.12

153.39

2.1

1.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2823

8477

1.79

151.51

9.5

9.1

1.58

1.34

21.04

2810

8426

(36304419) Bacteria [Presence] in Urine

10237

41143

1.39

151.32

3.5

2.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1196

2585

2.45

150.38

1.5

1.2

263.65

251.98

u/ml

0.69

797

1677

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1241

2746

2.40

148.56

1.7

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7504

28672

1.44

146.90

1.8

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1509

3661

2.19

146.88

1.8

1.5

0.23

0.24

g/l

4.88

1444

3495

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1226

2712

2.40

146.85

1.6

1.3

17.41

23.15

u/ml

0.69

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2803

8480

1.77

146.60

9.6

9.2

0.73

0.66

14.31

2792

8435

(3017569) Oxygen content in Arterial blood

441

495

4.69

146.53

1.9

2.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1542

3784

2.17

146.02

1.8

1.5

1.17

1.18

g/l

1.02

1471

3626

(3014007) Fractional oxyhemoglobin in Arterial blood

2813

8535

1.77

145.67

9.6

9.3

93.61

93.78

0.66

2806

8504

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

427

469

4.79

145.18

2.7

1.6

165.31

110.25

umol/l

2.03

224

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1150

2487

2.45

144.39

8.7

3.7

794.17

3917.93

iu/ml

0.65

230

261

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

789

1391

3.00

144.15

7.9

5.4

11.31

11.21

mg/l

0.19

734

1267

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6822

25718

1.45

142.88

2.6

3.2

2.44

2.45

mmol/l

12.33

6124

22285

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

755

1308

3.05

141.91

1.7

1.5

2586.67

5351.11

titre

0.48

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1900

5112

1.98

141.74

2.0

1.9

40.32

39.16

u/l

1.39

1733

4541

(3008757) Leukocyte morphology finding [Identifier] in Blood

675

1090

3.27

141.50

4.0

3.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2613

7823

1.79

141.31

2.4

2.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4527

15700

1.56

140.69

3.4

2.4

7.95

9.28

umol/l

2.61

3890

13474

(3007930) Methemoglobin/Hemoglobin.total in Blood

1807

4790

2.01

140.37

5.7

4.5

0.82

0.90

12.32

1704

4435

(3011397) Hemoglobin [Presence] in Urine by Test strip

8602

33973

1.40

139.01

4.6

2.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1793

4759

2.01

138.78

1.4

1.3

9.67

8.89

u/l

1.54

1501

3872

(3015736) pH of Urine

15023

64803

1.32

136.79

4.0

2.7

5.89

5.86

0.58

986

5910

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3862

12987

1.60

136.39

2.4

2.0

12.47

12.76

nmol/l

1.23

3485

11869

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

465

584

4.19

136.20

3.1

2.2

0.21

0.23

e9/l

1.08

410

484

(3048929) Epstein Barr virus Ab [Presence] in Serum

1860

5050

1.96

135.18

1.4

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

475

613

4.08

134.68

3.0

2.1

500.78

508.93

e6/l

0.12

410

484

(3000991) Gas panel - Venous blood

3551

11753

1.63

133.53

9.2

7.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1915

5293

1.93

132.22

1.6

1.5

11.69

13.17

u/ml

0.21

137

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

336

319

5.53

131.92

2.8

1.9

—

(3042517) Benzodiazepines panel - Urine

210

106

10.38

129.83

2.8

3.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1686

4484

2.00

129.65

1.7

1.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1045

2273

2.43

129.58

1.3

1.2

134.55

93.33

titre

0.40

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1563

4042

2.05

129.53

1.7

1.6

255.06

296.48

titre

0.23

172

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

560

849

3.47

128.67

2.1

2.2

19.86

18.85

nmol/l

1.19

530

817

(3011412) CD3 cells [#/volume] in Blood

625

1028

3.20

127.44

2.9

2.0

1.23

1.11

e9/l

2.35

562

919

(3045424) Erythrocytes [Presence] in Urine

947

1982

2.53

126.98

1.6

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

446

576

4.07

126.37

1.8

2.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

891

1825

2.58

124.62

4.1

2.1

722.73

4103.11

u/ml

2.12

(3010375) cycloSPORINE [Mass/volume] in Blood

362

395

4.81

123.98

32.0

23.8

121.83

127.25

ug/l

0.39

301

344

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3862

13271

1.57

123.96

3.8

3.7

1.23

1.22

mmol/l

3.89

3626

11294

(3023511) Choriogonadotropin [Units/volume] in Urine

1287

3137

2.17

123.67

1.5

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1016

2241

2.40

122.32

1.2

15.67

16.19

u/ml

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1490

3890

2.03

120.32

3.0

2.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1849

5227

1.88

119.26

1.8

1.6

1.51

1.52

g/l

0.12

1571

4404

(3003181) Sodium [Moles/volume] in Urine

918

1953

2.48

119.10

1.5

1.4

63.32

62.94

mmol/l

0.08

712

1519

(3004119) Hemoglobin [Mass/volume] in Venous blood

2554

7997

1.71

117.80

4.3

2.9

128.37

130.96

g/l

6.02

2486

7807

(40757494) Bilirubin.total [Moles/volume] in Blood

426

562

3.98

117.63

2.3

2.0

29.35

51.49

umol/l

1.21

(3035637) Corticotropin [Mass/volume] in Plasma

748

1439

2.74

117.61

1.5

—

(3047181) Lactate [Moles/volume] in Blood

1512

4005

2.00

117.41

6.7

4.9

1.38

1.28

mmol/l

2.43

1393

3440

(3021901) Oxygen saturation in Capillary blood

1112

2613

2.25

116.42

3.2

2.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1068

2472

2.29

115.72

1.7

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

644

1148

2.96

115.54

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3060

10130

1.62

114.21

3.8

2.5

183.70

210.59

ng/l

2.54

2788

9163

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1091

2565

2.25

114.08

1.7

1.3

120.84

104.53

u/ml

2.08

263

614

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1549

4193

1.96

113.24

1.7

1.6

28.21

2.28

iu/ml

1.06

322

883

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

669

1243

2.84

111.88

2.0

1.7

28.17

29.15

mg/l

0.13

197

390

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1199

2971

2.14

110.60

1.9

1.4

—

(3049717) Cytology report of Urine Cyto stain

1702

4801

1.88

110.37

2.8

2.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

743

1476

2.65

110.14

2.5

2.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

444

644

3.62

108.49

3.1

2.2

698.68

650.88

e6/l

0.93

431

615

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2065

6225

1.77

108.43

4.1

2.5

1.50

1.29

10.43

2057

6192

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

705

1379

2.69

107.56

1.2

—

(3014271) Vancomycin [Susceptibility]

345

414

4.37

106.61

3.4

2.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3553

12402

1.54

105.59

1.5

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

808

1713

2.49

105.55

1.4

1.2

—

(4200892) Spirometry reversibility

2755

9068

1.62

104.89

1.5

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

544

928

3.08

104.85

3.3

2.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3562

12509

1.53

102.87

2.2

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

481

768

3.29

102.61

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

483

775

3.28

102.29

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

375

506

3.89

100.73

2.5

2.3

144.15

148.36

nmol/l

0.22

337

408

(3038026) Centromere Ab [Units/volume] in Serum

450

699

3.38

99.96

1.2

86.11

51.20

u/ml

0.58

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2851

9579

1.59

99.68

2.0

1.6

—

(21494755) Public health laboratory ask at order entry panel

3158

24064

0.66

98.96

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

1078

2677

2.13

98.85

1.4

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2665

8826

1.61

98.81

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

207

156

6.95

98.80

2.4

1.9

1.18

1.20

mmol/l

1.43

197

146

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

629

1212

2.73

98.64

1.1

34.56

63.22

au/ml

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

440

684

3.38

97.64

1.2

77.13

61.77

u/ml

0.40

(3042733) HLA Ab [Presence] in Serum

282

305

4.85

97.57

4.5

5.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2071

6447

1.71

97.08

6.1

3.5

24.09

24.12

mmol/l

0.16

2032

6312

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

440

687

3.37

97.02

1.2

52.47

46.34

u/ml

0.17

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1067

2664

2.12

96.53

2.9

4.0

503.71

1072.80

u/ml

1.09

952

2441

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

312

376

4.35

95.99

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

312

377

4.34

95.71

1.5

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1232

3261

2.00

95.69

1.3

1.2

24.56

36.99

u/ml

1.04

213

(3024980) IgG subclass 4 [Mass/volume] in Serum

834

1882

2.34

95.56

1.6

1.5

0.69

0.85

g/l

3.23

688

1294

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

587

1112

2.78

94.92

1.4

1.3

1.62

1.41

nmol/l

3.72

540

1005

(36660697) Celiac disease serology panel - Serum

3181

11123

1.53

93.28

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1220

3253

1.98

92.86

2.1

2.0

11.35

10.26

mg/l

1.40

1134

3079

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3756

13619

1.48

92.69

3.6

4.3

21.84

33.12

ug/l

1.19

3047

10867

(3024932) HLA-DR beta [Type]

278

312

4.67

92.54

1.1

—

(3024471) HLA-A [Type]

283

323

4.59

92.52

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

936

2254

2.19

92.48

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2384

7809

1.63

92.18

1.1

1.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

596

1158

2.71

92.09

1.8

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

596

1160

2.70

91.80

1.8

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

31822

154578

1.26

91.75

19.0

12.9

14.93

14.78

0.80

31528

150853

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

419

658

3.34

91.64

1.2

4.45

6.84

u/ml

0.36

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1149

3016

2.01

91.27

1.3

1.2

7.44

9.89

u/ml

0.56

209

417

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

909

2178

2.20

90.89

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1274

3487

1.93

90.07

2.0

1.8

193.47

201.42

pmol/l

1.54

1206

3332

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1986

6238

1.69

90.00

2.4

2.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1133

2975

2.01

89.91

1.3

1.2

2.55

10.95

u/ml

2.56

136

274

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

494

875

2.97

89.64

1.1

281.42

261.39

mg/l

0.50

447

751

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1717

5182

1.76

89.52

1.9

1.6

40.01

40.07

nmol/l

0.03

1660

5106

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

282

335

4.41

88.23

2.6

2.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8097

33650

1.31

88.18

1.7

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

280

331

4.44

88.08

2.4

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

283

338

4.39

88.01

2.4

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

279

331

4.42

87.42

2.4

1.9

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

503

919

2.88

86.66

1.2

1.1

44.43

44.78

mg/l

0.03

445

734

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

935

2318

2.13

86.07

1.3

1.2

4.25

7.31

u/ml

0.60

177

(3034770) Mitochondria Ab [Titer] in Serum

1279

3565

1.90

85.73

1.2

642.26

1180.51

titre

2.17

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

374

569

3.45

85.65

1.5

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

365

549

3.49

84.94

1.1

1.62

9.38

nmol/l

2.01

133

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

185

147

6.59

84.79

1.7

1.4

121.52

121.74

ng/l

0.00

185

147

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

369

562

3.45

84.38

1.5

1.3

—

(4062490) Immunoglobulin typing, IgG

584

1179

2.61

84.03

1.5

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

581

1179

2.59

82.78

1.4

1.3

2.90

3.04

g/l

0.95

478

692

(3007566) Smooth muscle Ab [Titer] in Serum

1285

3636

1.87

82.31

1.3

1.2

105.67

133.99

titre

0.53

141

368

(1175426) CD3 cells/100 lymphocytes in Blood

474

863

2.89

82.17

2.5

1.9

72.52

72.42

0.04

454

834

(3027135) IgG subclass 1 [Mass/volume] in Serum

580

1181

2.58

82.10

1.4

1.3

6.40

7.02

g/l

2.91

479

691

(3024139) IgG subclass 3 [Mass/volume] in Serum

579

1179

2.58

81.96

1.4

1.3

0.36

0.42

g/l

3.57

480

688

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1091

2936

1.96

80.89

2.0

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

642

1386

2.44

80.86

1.3

—

nmol/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

593

1233

2.53

80.59

2.7

1.46

1.30

g/24h

0.65

347

672

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

701

1581

2.33

80.45

1.1

1.98

2.01

iu/ml

0.02

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

479

890

2.83

80.20

1.3

1.2

2.03

2.11

mmol/l

0.66

450

828

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

465

851

2.87

79.92

2.5

1.8

14.61

15.49

0.78

452

832

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

556

1127

2.59

79.41

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

709

1617

2.31

79.39

1.3

0.19

0.25

nmol/l

0.68

107

(3020961) Endomysium IgA Ab [Titer] in Serum

2156

7144

1.60

79.32

1.1

280.36

250.91

titre

0.13

214

(3034988) Calcium [Moles/volume] in Capillary blood

200

191

5.48

78.28

2.3

2.0

1.17

1.19

mmol/l

0.94

191

177

(3021387) Prolactin [Units/volume] in Serum or Plasma

1936

6279

1.64

77.55

1.6

336.60

292.57

mu/l

4.78

1809

5575

(3027923) C peptide [Moles/volume] in Serum or Plasma

343

527

3.41

77.51

1.7

1.6

1.29

1.24

nmol/l

0.30

271

439

(3016244) Insulin [Units/volume] in Serum or Plasma

410

710

3.03

77.26

3.3

3.1

27.24

27.96

mu/l

0.12

386

680

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

826

2035

2.14

77.23

1.4

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1318

3839

1.82

77.12

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

224

244

4.81

77.04

3.4

2.8

—

(3000034) Microalbumin [Mass/volume] in Urine

485

930

2.74

76.82

3.4

2.8

69.12

46.90

mg/l

0.81

353

643

(42529406) Shigella sp [Presence] in Stool by Culture

1318

3845

1.81

76.73

1.2

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

447

821

2.86

76.37

2.6

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12097

53669

1.24

75.52

4.5

4.4

3.29

3.07

ug/l

0.19

10986

48278

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

566

1189

2.50

75.39

1.4

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2995

10797

1.48

75.38

1.2

120.62

149.97

iu/ml

2.90

1102

4281

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1303

3817

1.80

74.85

1.2

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

354

572

3.25

74.32

1.8

1.5

2778112.00

1242353.00

iu/ml

1.19

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1492

4567

1.73

73.94

1.8

1.6

—

(40761536) Microorganisms panel - Urine sediment

2362

18069

0.66

73.88

4.7

3.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

460

876

2.76

73.78

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

695

1626

2.25

73.49

1.3

0.59

2.35

nmol/l

1.11

677

1556

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1135

3202

1.87

73.33

2.4

2.2

133.11

117.22

ug/min

0.44

776

1921

(3019832) Treponema pallidum Ab [Presence] in Serum

4951

19610

1.36

73.32

1.8

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1247

3627

1.82

73.28

1.2

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1373

4121

1.76

72.78

2.3

2.1

7.29

7.41

g/l

1.64

1220

3737

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1316

3907

1.78

72.35

2.3

2.1

2.67

3.03

g/l

25.94

1163

3525

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1370

4118

1.76

72.26

2.3

2.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

101

13.90

72.08

4.7

2.3

2.18

2.47

mg/l

0.35

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1224

3562

1.82

71.80

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1366

4114

1.76

71.57

2.3

2.1

3.52

3.85

g/l

8.26

1217

3731

(3023419) Bacteria identified in Sputum by Culture

700

1662

2.22

71.54

2.9

2.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1069

2983

1.89

71.37

1.8

1.6

14873.49

13813.86

e6/l

0.24

830

2106

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

645

1484

2.29

70.86

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

895

2371

1.99

69.31

1.1

—

(3010503) CD19 cells [#/volume] in Blood

385

687

2.94

69.12

3.0

2.2

0.45

0.21

e9/l

0.54

374

671

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

987

2719

1.91

68.44

4.1

2.8

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

317

507

3.28

67.63

1.7

1.3

23.84

29.60

umol/l

1.96

296

477

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1307

3953

1.75

67.48

1.4

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

475

974

2.56

66.42

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

395

737

2.81

65.75

1.5

1.8

—

(3010838) Calcium [Moles/time] in 24 hour Urine

791

2056

2.03

64.51

1.8

1.9

5.04

5.39

mmol/24h

1.83

715

1864

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

231

303

3.99

64.47

2.4

1.3

34359.29

2159.61

u/ml

0.71

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

781

2021

2.03

64.45

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

289

451

3.36

63.95

1.4

1.6

8.88

7.25

ug/l

0.54

270

398

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

580

1337

2.28

63.49

1.2

27.20

21.57

nmol/l

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1612

5248

1.63

63.45

1.3

203.13

230.27

miu/ml

2.18

681

2544

(3008295) Osmolality of Serum or Plasma

550

1241

2.33

63.14

1.5

1.4

281.27

279.40

mosm/kgh2o

0.92

435

976

(3006245) CD3-CD19+ cells/100 cells in Blood

256

373

3.60

62.39

2.9

1.8

10.85

0.00

240

351

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1269

3897

1.72

62.12

6.1

2.8

1.53

1.46

mg/l

1.79

1209

3599

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

345

617

2.93

61.77

1.3

1.4

5.57

5.97

u/l

0.25

295

524

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1104

3260

1.79

61.75

1.5

1.4

14.20

13.48

iu/ml

0.05

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1363

4294

1.68

60.82

3.7

2.3

3.47

3.70

g/l

5.91

1295

4094

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2815

20169

0.71

60.59

1.6

1.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

462

984

2.47

59.94

2.7

2.0

39.74

38.09

1.21

452

970

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

199

245

4.25

59.94

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

199

245

4.25

59.94

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

199

245

4.25

59.94

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

199

245

4.25

59.94

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

346

643

2.82

58.06

1.1

—

(3036489) Thrombin time

1620

5401

1.59

57.84

2.8

1.8

21.07

21.34

0.80

1356

4690

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

242

359

3.53

57.59

2.7

1.7

29.07

28.84

0.07

230

340

(3044927) Protein electrophoresis panel - Urine

421

874

2.53

57.53

1.2

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

419

876

2.51

56.47

1.1

289.22

286.19

mg/l

0.30

380

795

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1425

4632

1.63

56.39

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1339

4296

1.65

55.75

4.0

2.9

0.34

0.35

u/ml

0.98

841

2330

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

662

1701

2.05

55.71

1.1

1.51

g/l

0.08

599

1554

(40760888) Immunoglobulin light chains.free panel - Serum

936

2714

1.82

55.55

3.6

3.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

819

2279

1.89

55.17

2.0

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

181

221

4.29

55.09

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

298

527

2.96

54.43

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

298

528

2.96

54.26

3.1

2.4

39.49

38.49

0.35

218

265

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

339

653

2.72

53.42

1.1

1.02

1.11

u/l

0.95

148

309

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1163

3638

1.69

53.26

3.5

3.1

47.27

43.84

mg/l

0.13

1043

2623

(3014148) Varicella zoster virus Ab [Titer] in Serum

723

1951

1.95

53.25

1.2

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

126

111

5.94

53.17

1.5

1.4

133.75

59.59

titre

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1165

3651

1.68

52.99

3.5

3.1

50.99

63.95

mg/l

0.65

1044

2636

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1133

3526

1.69

52.87

3.4

3.1

2.46

4.63

ratio

0.42

275

203

(3048879) Bone marrow aspiration report

170

204

4.36

52.80

2.5

1.6

—

(3028433) Virus identified in Specimen by Culture

217

319

3.56

52.35

1.3

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

524

1259

2.19

52.19

2.8

3.3

7.91

9.46

nmol/l

0.12

510

1228

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

434

960

2.37

52.10

1.3

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2293

8420

1.44

51.97

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

9624

43016

1.21

51.89

3.9

21.53

21.89

1.38

4369

19650

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

319

605

2.76

51.71

1.0

269.54

334.64

ng/l

3.38

212

474

(3022621) pH of Urine by Test strip

2447

9103

1.43

51.71

3.2

2.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

684

1830

1.97

51.62

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

27.55

51.50

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

320

610

2.75

51.41

1.0

36.68

41.83

ng/l

1.43

212

470

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

320

611

2.75

51.26

1.0

826.57

712.06

ng/l

3.04

207

455

(3013005) Retinol [Moles/volume] in Serum or Plasma

251

415

3.17

51.07

2.3

1.5

1.90

1.97

umol/l

0.51

232

387

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

350

706

2.60

50.65

3.2

1.7

95.41

97.85

0.58

329

658

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

225

348

3.39

50.56

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1458

4895

1.57

50.50

1.6

1.7

—

(1761868) Lipid panel - Serum or Plasma

12295

72466

0.84

50.21

2.3

2.6

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

329

647

2.67

49.95

2.5

3.7

134.50

128.64

nmol/l

0.08

319

638

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

140

149

4.91

49.50

6.2

4.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

467

1097

2.23

49.08

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

277

506

2.87

47.99

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

126

125

5.27

47.76

1.8

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1344

4487

1.58

47.66

1.9

1.7

—

(3008898) HLA-B27 [Presence]

1555

5383

1.53

47.04

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

347

726

2.51

46.80

1.4

1.2

5.12

5.53

umol/l

1.00

317

683

(3014051) Protein [Presence] in Urine by Test strip

864

2579

1.76

46.67

2.5

2.1

—

(3022689) Creatine [Moles/volume] in Urine

192

281

3.58

46.66

1.6

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

259

464

2.92

46.39

1.1

8.18

8.15

u/ml

0.00

(3037756) Immunofixation for Serum or Plasma

789

2305

1.80

45.76

1.7

1.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

160

208

4.02

45.31

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

187

275

3.56

45.17

3.0

1.7

205.38

1558.89

e6/l

0.80

104

135

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

298

587

2.66

45.17

1.2

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

212

343

3.24

44.66

1.2

—

(40757373) Influenza virus identified in Isolate

156

202

4.04

44.40

1.6

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

257

473

2.85

44.00

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

369

822

2.35

43.73

1.8

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

243

435

2.93

43.62

1.8

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

478

1192

2.10

43.55

1.4

1.3

135948.46

95239.88

e6/l

0.64

355

818

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

305

622

2.57

43.31

1.2

1.3

59.76

68.26

0.57

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

278

546

2.67

42.40

1.9

1.7

141.12

141.93

0.05

263

515

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1887

13658

0.71

42.40

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5640

24300

1.24

42.19

3.0

2.5

1.09

1.34

e6/l

1.08

3681

11982

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1069

3481

1.62

42.00

1.8

1.9

11.79

9.99

iu/l

0.07

396

1338

(3006576) Bicarbonate [Moles/volume] in Blood

246

456

2.82

41.64

6.2

5.5

24.97

25.04

mmol/l

0.08

232

401

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

753

2239

1.77

41.25

1.6

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

264

512

2.70

41.23

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

367

839

2.29

41.12

1.3

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

110

111

5.18

41.08

1.5

1.3

45.40

54.25

0.81

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

329

719

2.40

40.66

1.9

1.7

2.90

2.40

u/field

0.30

163

571

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

225

402

2.93

40.56

1.2

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1342

4648

1.52

40.49

3.4

2.0

93.06

91.87

1.02

1286

4449

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

294

610

2.52

40.40

3.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

197

327

3.15

39.97

1.2

111.28

110.53

0.13

179

290

(3017817) Protein [Mass] in Urine collected for unspecified duration

419

1027

2.14

39.90

2.8

2.3

0.48

0.80

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1948

7291

1.41

39.62

11.6

9.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

845

2631

1.69

39.42

1.3

1.2

32.29

47.38

u/ml

2.13

266

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

659

1910

1.81

39.27

1.4

1.3

37.08

28.05

u/l

0.97

576

1641

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

238

448

2.78

39.25

2.7

2.8

28.46

28.43

umol/l

0.01

173

340

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6050

26457

1.22

39.08

1.5

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

207

360

3.01

39.03

1.4

14.82

15.05

pmol/l

0.12

169

310

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

235

443

2.78

38.66

2.4

1.4

28.04

29.32

umol/l

0.95

225

423

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

128

158

4.24

38.63

1.7

1.3

100.84

101.26

ng/l

0.00

105

(3047007) Chlamydophila sp Ab [Presence] in Serum

692

2049

1.77

38.47

1.2

—

(3011985) Renin [Units/volume] in Plasma

617

1763

1.84

38.47

1.6

1.5

62.96

67.92

mu/l

0.20

559

1575

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1161

3946

1.55

38.14

2.2

2.1

9.57

10.37

g/l

7.73

1001

3543

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

612

1752

1.83

37.94

1.5

58.99

57.20

0.47

393

1095

(3037692) Legionella sp identified in Specimen by Organism specific culture

194

332

3.06

37.56

1.6

1.3

—

(21494434) Karyotype in Bone marrow

365

867

2.21

37.52

1.3

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

319

717

2.33

37.17

1.5

22.54

25.44

u/ml

0.35

146

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1202

4146

1.53

36.96

3.5

2.2

179.45

187.76

2.46

1140

3934

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

529

1458

1.90

36.81

1.3

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

366

878

2.18

36.76

1.1

—

(3007463) Buprenorphine [Presence] in Urine

8.01

36.74

5.3

12.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

366

882

2.17

36.37

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

126

163

4.04

36.00

1.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

201

363

2.90

35.66

1.2

0.31

g/l

0.16

165

281

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

297

660

2.36

35.50

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

20.42

35.28

1.7

1.1

—

(40768446) Kidney Pathology biopsy report

241

487

2.59

34.95

1.9

1.5

—

(3016038) Potassium [Moles/volume] in Urine

323

751

2.25

34.93

1.3

1.2

32.97

35.52

mmol/l

0.95

280

657

(40768443) Skin Pathology biopsy report

1645

6115

1.42

34.73

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1164

4050

1.51

34.40

1.1

5.37

4.83

u/ml

0.16

130

691

(3023323) Follitropin [Units/volume] in Serum or Plasma

2093

8120

1.36

34.31

1.4

1.3

24.39

27.35

iu/l

3.72

1841

6874

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

282

622

2.37

34.27

1.1

24.84

22.43

u/l

0.21

266

550

(3006922) Hepatitis E virus Ab [Presence] in Serum

384

968

2.08

34.17

1.1

—

(3039000) Anion gap in Blood

861

2804

1.61

33.88

9.3

5.8

11.25

11.34

mmol/l

0.32

793

2483

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

573

1666

1.80

33.87

1.4

317.67

303.57

pmol/l

0.29

507

1456

(3018572) Chloride [Moles/volume] in Blood

861

2805

1.61

33.83

9.3

5.8

104.95

105.02

mmol/l

0.14

793

2484

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

280

624

2.35

33.30

1.1

82.14

83.19

u/l

0.07

268

546

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

663

2026

1.72

33.16

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

163

271

3.15

33.09

1.2

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

10.07

33.08

4.0

4.9

—

(3020393) Adenovirus Ag [Presence] in Stool

106

4.73

32.83

1.7

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

114

147

4.05

32.75

1.2

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

516

1469

1.84

32.63

1.1

1.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1515

5615

1.42

32.51

1.1

11.19

4.08

u/ml

0.40

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1063

3673

1.52

32.46

2.3

2.4

0.86

0.84

g/l

0.05

902

3146

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

696

2172

1.68

32.28

1.2

1.1

115.05

117.68

1.20

647

1951

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1824

6990

1.38

32.25

10.2

9.8

24.20

24.34

mmol/l

1.10

1748

6759

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

741

2353

1.65

32.21

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

826

2698

1.61

32.14

2.9

1.5

0.97

0.82

nmol/l

4.97

696

2375

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

164

279

3.07

32.14

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

163

278

3.07

31.82

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

163

279

3.06

31.64

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

283

650

2.28

31.53

1.4

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

218

442

2.58

31.47

1.1

468.28

406.23

ng/l

0.07

115

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

284

654

2.27

31.46

1.2

1.1

1650.53

1452.99

miu/ml

1.87

284

654

(21494890) Protein electrophoresis panel - 24 hour Urine

428

1159

1.94

31.43

2.0

1.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

612

5235

0.60

31.39

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

8587

39442

1.17

31.31

4.7

3.4

91.58

90.25

4.78

8289

38502

(3017509) Phencyclidine [Presence] in Urine

131

195

3.51

31.29

2.8

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

630

5346

0.61

31.25

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

729

2326

1.65

31.13

1.3

1.2

4.10

3.90

u/ml

0.09

263

819

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

715

2273

1.65

30.96

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

359

918

2.05

30.85

1.1

1.2

1.07

ratio

0.08

424

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

105

133

4.13

30.84

1.1

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

637

1967

1.70

30.73

1.5

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5184

22819

1.21

30.72

3.5

2.6

3.24

2.81

e6/l

1.56

3257

10551

(3005033) Fetal Nuchal fold Thickness US

615

5226

0.61

30.69

1.4

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

253

562

2.36

30.36

2.7

2.3

55.54

50.84

umol/l

1.28

219

471

(3023410) Appearance of Cerebral spinal fluid

472

1343

1.84

29.94

1.8

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

204

413

2.58

29.57

1.1

1.2

108.12

106.62

0.17

185

375

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

152

262

3.03

29.22

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

352

913

2.02

29.16

1.3

1.2

2.06

2.26

u/ml

0.12

224

406

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

5.71

29.14

1.6

1.4

42.43

35.56

0.49

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

227

490

2.42

28.97

1.4

516.30

886.23

mu/l

0.90

216

470

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

570

1737

1.72

28.86

1.5

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

681

2180

1.64

28.75

1.3

1.2

3.62

3.95

u/ml

0.39

302

996

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

257

591

2.28

28.61

1.3

1.2

55.77

103.78

titre

0.61

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

543

1636

1.74

28.60

1.8

27.55

27.01

ug/l

0.05

526

1616

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.68

28.47

4.6

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3099

13017

1.26

28.36

3.0

2.3

67.99

43.56

u/l

0.66

2640

11212

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

200

411

2.55

28.20

1.1

91.54

92.15

0.08

103

185

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

10.01

28.11

4.6

1.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

229

504

2.38

28.08

1.4

74.24

72.67

0.95

218

484

(3011335) Digoxin [Mass/volume] in Serum or Plasma

5.30

28.00

2.4

2.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

263

621

2.22

27.58

1.3

1.2

231.67

515.45

titre

1.06

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

327

844

2.03

27.49

2.0

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.92

27.44

3.6

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

232

521

2.33

27.25

3.0

2.3

134.49

147.06

au/ml

0.11

(3027456) Digoxin [Moles/volume] in Serum or Plasma

672

2174

1.62

27.25

3.0

0.83

0.81

nmol/l

0.29

493

1725

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

128

3.96

27.18

1.2

1.0

—

(3016228) CD19 cells/100 cells in Blood

231

519

2.33

27.11

2.4

1.9

8.65

7.90

0.34

223

508

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

194

401

2.53

27.06

1.1

1.2

93.22

92.50

0.08

101

184

(3001186) Copper [Moles/volume] in Serum or Plasma

147

262

2.93

26.81

1.4

1.2

16.75

16.66

umol/l

0.08

131

231

(3024928) Oxygen saturation in Venous blood

809

2747

1.55

26.80

4.4

2.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

180

361

2.61

26.63

1.1

1.0

9.01

11.44

u/ml

0.60

108

239

(3016750) Collection duration of Urine

323

840

2.01

26.63

2.5

1.9

502.35

502.25

min

0.01

295

564

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

573

1797

1.67

26.20

1.6

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

198

422

2.45

26.00

1.1

1.3

12.68

20.23

0.74

(3022493) Free Hemoglobin [Mass/volume] in Plasma

236

546

2.26

25.98

8.7

4.0

67.25

4710.35

mg/l

3.28

179

370

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

330

874

1.98

25.91

1.6

1.4

13.09

12.41

u/l

0.73

312

849

(21494814) CD8 cells/100 lymphocytes in Specimen

224

508

2.31

25.79

2.4

1.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

330

878

1.97

25.59

1.2

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

490

1483

1.73

25.48

1.5

29.11

31.67

0.79

305

918

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

243

580

2.19

24.91

3.4

2.9

7.45

8.51

mg/l

1.40

213

436

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

617

2002

1.62

24.77

1.9

2.2

32.70

32.75

0.10

610

1986

(3042111) Morphology [Interpretation] in Bone marrow Narrative

599

1931

1.63

24.68

1.8

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

681

2268

1.58

24.57

1.1

12.92

11.63

au/ml

0.10

187

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

316

843

1.96

24.35

1.3

1.4

5.60

5.54

mmol/l

0.32

295

795

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.41

24.21

2.2

1.9

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

193

421

2.40

24.20

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

113

183

3.23

24.03

2.4

2.2

—

(3001556) Androgen free Index in Serum or Plasma

119

3.86

23.97

1.3

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

14.36

23.94

6.8

1.5

—

(3003694) ABO and Rh group [Type] in Blood

10874

51590

1.13

23.91

1.5

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

5.40

23.88

1.6

1.4

13.29

14.58

0.13

(3018133) Calcium [Moles/volume] in Urine

102

155

3.44

23.80

2.6

1.7

2.47

2.62

mmol/l

0.27

140

(3017704) Immunofixation for Urine

218

507

2.25

23.76

1.6

1.5

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

194

429

2.37

23.64

2.1

2.6

1.33

1.20

ug/l

0.21

182

401

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

264

668

2.07

23.47

1.1

97.09

95.99

0.23

228

515

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

101

154

3.43

23.46

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

307

822

1.96

23.44

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

149

3.47

23.42

3.5

2.8

40.17

46.02

umol/l

1.45

129

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.74

23.40

2.3

2.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

5.22

23.15

1.0

0.07

0.11

u/ml

0.20

(3016018) Differential panel - Cerebral spinal fluid

478

1480

1.69

22.98

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

113

189

3.13

22.90

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

10.17

22.82

3.1

3.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

240

593

2.12

22.68

1.3

1.2

164.52

167.00

mmol/24h

0.14

240

593

(40768441) Liver Pathology biopsy report

338

949

1.86

22.49

1.6

1.2

—

(4035726) Immunohistochemistry procedure

3102

13365

1.23

22.43

1.5

1.4

—

(40765096) Chromosome analysis panel by Banding

150

300

2.61

22.40

1.1

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

144

3.45

22.27

1.9

1.2

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

475

1488

1.67

21.91

2.4

2.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

591

1958

1.58

21.86

1.6

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

110

187

3.07

21.76

1.5

1.4

0.41

0.46

ug/l

0.54

124

(3051387) C reactive protein [Mass/volume] in Capillary blood

527

4283

0.64

21.71

4.1

3.0

23.85

27.64

mg/l

1.34

249

2825

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

187

426

2.30

21.42

2.0

1.7

170.22

160.12

0.52

179

393

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

400

1203

1.74

21.36

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

676

2323

1.53

21.33

2.6

2.2

7.00

6.24

umol/l

0.51

502

1702

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

613

4802

0.66

21.16

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

142

285

2.60

21.10

1.6

1.5

9.32

9.23

ug/l

0.07

142

285

(3024263) Appearance of Synovial fluid

239

610

2.05

20.84

1.7

1.3

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

5.22

20.53

1.5

1.3

1.12

0.98

0.10

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

161

3.18

20.47

1.1

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

166

367

2.37

20.33

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

154

3.22

20.25

1.2

—

(3042631) Mycobacterium sp identified in Specimen

586

1976

1.55

20.15

2.8

2.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

896

3298

1.43

20.10

2.2

0.04

0.02

g/l

0.81

812

3012

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

338

985

1.80

20.08

1.4

1.3

12.26

11.94

umol/l

0.39

323

941

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

181

420

2.25

19.93

3.4

2.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

241

628

2.01

19.92

3.9

3.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

482

1555

1.62

19.92

1.3

1.2

54.79

49.27

u/ml

0.16

104

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

415

1294

1.68

19.54

1.2

64.77

68.82

u/l

0.36

390

1144

(40763590) HLA-DQ beta [Type]

7.27

19.53

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

754

2702

1.46

19.49

1.5

1.4

0.36

0.43

nmol/l

0.88

581

2150

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

839

6111

0.71

19.45

1.5

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

3.62

19.40

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

975

3671

1.39

19.26

1.7

1.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

165

3.07

19.23

2.2

1.5

46.44

55.03

pmol/l

0.29

137

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

7.35

19.17

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

123

241

2.67

19.17

1.8

1.2

—

(3013862) HLA-DP [Type]

7.02

19.04

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

903

3372

1.41

18.72

2.0

2.1

38.04

37.62

g/l

1.00

747

2987

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

509

1691

1.58

18.70

1.1

—

(40760410) HLA-B [Type] by High resolution

6.79

18.57

1.0

—

(40760409) HLA-A [Type] by High resolution

6.79

18.57

1.0

—

(46236302) HLA-C [Type] by High resolution typing

6.79

18.57

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

231

609

1.98

18.54

1.3

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

137

3.24

18.32

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

104

191

2.85

18.21

1.1

0.66

0.96

umol/24h

0.45

(3017315) Amylase [Enzymatic activity/volume] in Urine

293

843

1.82

18.20

1.3

1.2

269.76

389.58

u/l

1.02

273

797

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

133

3.26

18.06

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

158

362

2.28

17.96

2.1

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

194

485

2.09

17.93

4.0

13.8

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

148

3.11

17.80

8.7

6.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2969

18305

0.84

17.79

3.7

3.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

149

334

2.33

17.78

1.3

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

681

2438

1.46

17.74

1.4

1.3

7.14

6.94

mmol/l

1.04

630

2173

(3034426) Prothrombin time (PT)

178

432

2.15

17.71

1.3

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

135

290

2.43

17.64

1.4

1.2

129.13

126.36

nmol/l

0.06

110

206

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

831

5956

0.72

17.48

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

209

544

2.01

17.41

1.5

2.01

5.02

nmol/l

2.09

178

455

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

479

1597

1.57

17.37

1.2

1.1

94.79

96.78

0.78

458

1499

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

838

5988

0.73

17.29

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

839

5994

0.73

17.29

1.4

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

113

3.42

17.28

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

837

5980

0.73

17.26

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

174

423

2.15

17.26

1.2

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

169

407

2.17

17.15

1.4

1.3

177.72

307.69

nmol/24h

0.47

169

407

(3045142) Bone marrow Pathology biopsy report

406

1305

1.63

17.11

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

114

230

2.59

16.88

1.5

1.3

22.12

22.03

0.01

101

188

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1603

6621

1.27

16.83

1.8

1.6

4.53

3.69

mg/l

1.63

1283

4509

(3009871) Measles virus Ab [Titer] in Serum

182

456

2.09

16.77

1.6

1.7

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

175

2.84

16.59

1.1

4.40

12.38

pmol/l

0.44

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

5.00

16.47

1.0

0.16

2.50

u/ml

0.51

(3038071) Oxygen [Partial pressure] in Mixed venous blood

120

252

2.49

16.45

15.7

5.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

251

2.48

16.18

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

749

2783

1.41

16.05

2.5

2.7

1.57

1.64

mmol/l

0.70

723

2725

(44813793) Dust mix specific IgE antibody measurement

332

1032

1.68

15.93

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

269

787

1.79

15.91

1.3

1.5

12.12

6.32

u/l

4.20

231

594

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

382

1234

1.62

15.83

4.3

5.1

129.58

92.73

u/ml

0.34

114

448

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

163

401

2.13

15.75

1.8

1.6

86.97

140.54

au/ml

0.74

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

8.60

15.70

2.1

1.4

150.50

180.75

nmol/l

0.23

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

124

3.16

15.63

1.2

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

127

3.13

15.58

1.2

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

189

497

1.99

15.38

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

191

505

1.98

15.32

2.0

1.8

8.56

9.64

mg/l

1.69

165

383

(3004775) Volume in Urine collected for unspecified duration

355

1138

1.63

15.19

3.0

1.9

681.19

701.10

0.39

327

706

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

113

3.24

15.14

1.1

1.2

40.87

48.43

mg/l

1.05

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

+∞

15.08

1.0

0.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

133

306

2.27

15.07

15.0

6.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.78

15.06

1.1

1.2

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

4.45

14.94

1.3

1.1

28.53

16.53

0.66

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

5.22

14.91

11.1

10.7

105.53

214.36

e6/l

1.12

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

245

715

1.79

14.66

1.2

21.00

20.23

u/ml

0.02

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

931

3644

1.34

14.56

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1836

11623

0.82

14.53

1.4

1.5

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.63

14.50

2.5

1.7

1.21

1.29

umol/l

0.79

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

157

2.80

14.37

2.5

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

131

307

2.23

14.27

1.2

41.50

40.83

g/l

0.20

167

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.96

14.20

1.5

1.7

1.95

1.90

mg/l

0.02

(40758292) HTLV I+II Ab panel - Serum

107

229

2.44

14.19

1.4

1.3

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

195

2.57

14.12

1.1

1.2

308.29

186.10

titre

—

(3028717) Thiamine [Mass/volume] in Blood

105

3.23

14.07

1.2

1.1

—

(3000012) Reticulocyte production index

605

2217

1.43

14.07

2.0

2.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

119

269

2.31

14.06

1.2

77.89

78.58

0.04

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.34

13.91

31.1

4.0

—

(3002256) Pathology report gross observation

4519

20906

1.14

13.85

1.3

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

3.37

13.80

1.0

1.1

0.34

4.09

u/ml

2.61

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

227

660

1.80

13.78

6.0

4.5

53.43

1523.52

u/ml

0.79

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

647

2411

1.41

13.72

1.1

11325.39

815.22

iu/ml

0.45

196

514

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.52

13.71

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

259

785

1.73

13.69

1.2

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

162

421

2.01

13.68

1.5

1.3

55.98

56.73

0.08

135

362

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

156

2.75

13.63

1.1

1.3

29.59

48.31

mg/l

3.56

131

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

156

2.75

13.63

2.3

2.8

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

120

277

2.26

13.56

1.2

85.74

87.49

0.11

(3009015) Lactate [Moles/volume] in Synovial fluid

3.57

13.46

1.2

1.3

5.75

5.67

mmol/l

0.03

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

101

3.21

13.28

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

3.04

13.24

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.86

13.23

1.2

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

118

3.01

13.21

1.3

1.2

559.60

76.51

u/l

0.44

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.55

13.12

1.3

1.1

19.28

13.40

nmol/l

1.24

(3030313) Adrenal Ab [Titer] in Serum

103

3.14

12.90

1.1

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.83

12.88

1.5

1.7

2.77

3.73

mg/l

0.38

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.83

12.88

1.5

1.7

1.47

2.19

mg/l

0.45

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.83

12.88

1.5

1.7

0.98

1.57

mg/l

0.34

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.83

12.88

1.5

1.7

0.53

0.63

mg/l

0.16

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.83

12.88

1.5

1.7

1.86

2.04

mg/l

0.06

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.83

12.88

1.5

1.7

1.48

2.16

mg/l

0.39

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.83

12.88

1.5

1.7

1.91

3.83

mg/l

1.06

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.83

12.88

1.5

1.7

2.65

1.11

mg/l

0.61

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.83

12.88

1.5

1.7

2.09

3.12

mg/l

0.44

(3023487) Leukocytes [#/volume] in Peritoneal fluid

161

428

1.97

12.82

2.9

1.6

2857.68

2786.16

e6/l

0.01

140

263

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

295

944

1.63

12.80

1.7

4.06

3.86

mg/l

0.23

279

888

(3034891) Synovial lining cells/100 cells in Synovial fluid

258

797

1.69

12.78

1.4

4.03

4.27

0.07

204

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.74

12.75

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.07

12.68

1.3

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.18

12.49

1.3

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

6.41

12.35

6.4

11.5

44.55

43.93

0.02

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1717

7409

1.22

12.25

3.3

59.08

50.86

u/ml

0.19

1672

7177

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.99

12.09

1.3

1.6

11.48

17.89

nmol/l

1.01

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

168

464

1.89

12.03

2.3

1.9

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

5.22

11.90

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

330

1106

1.56

11.90

1.2

1.1

345.56

394.83

nmol/l

3.59

311

935

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

334

1123

1.56

11.88

2.2

2.0

2.03

1.99

u/field

0.04

138

459

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

142

2.69

11.72

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.81

11.70

2.2

1.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

124

310

2.09

11.66

1.3

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

125

2.80

11.59

7.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.59

11.59

1.3

1.4

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.27

11.53

1.3

1.25

1.27

ml/s/173m2

0.02

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

109

260

2.19

11.50

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

128

328

2.04

11.31

1.2

1.3

34.95

38.68

0.50

237

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.05

11.17

1.4

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

347

1194

1.52

11.16

1.4

1.3

376.84

511.71

u/l

1.47

330

1131

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

108

260

2.17

11.16

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

3.19

11.14

1.0

1.1

0.17

7.18

u/ml

0.64

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

3.32

11.13

1.0

1.1

0.20

0.37

u/ml

0.27

(3011841) English Walnut IgE Ab [Units/volume] in Serum

3.01

11.12

1.0

1.1

0.87

12.29

u/ml

1.50

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

199

2.34

10.89

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

253

815

1.62

10.79

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

5.22

10.76

6.8

9.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

901

3670

1.29

10.72

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

588

2254

1.37

10.66

1.7

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6570

31511

1.10

10.64

2.9

2.8

0.71

0.79

ug/l

7.94

3999

19256

(1616796) Gas panel - Central venous blood

933

3824

1.28

10.58

3.8

3.5

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.94

10.55

1.4

1.1

0.07

0.08

g/l

0.03

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

3.00

10.52

1.4

9.41

20.85

pmol/l

1.23

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

287

960

1.56

10.50

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

3.10

10.45

1.0

1.1

0.15

1.56

u/ml

0.75

(3006184) Hemoglobin [Mass/volume] in Capillary blood

895

3656

1.28

10.43

2.3

2.2

131.87

131.43

g/l

0.19

669

2854

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1273

5425

1.23

10.31

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.31

10.19

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

110

1091

0.52

10.11

1.2

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

203

629

1.69

10.07

2.2

2.3

20.75

178.09

ug/l

0.88

195

598

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.28

10.06

1.5

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

108

273

2.07

9.95

2.8

2.7

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

195

2.28

9.88

1.9

1.3

0.19

0.25

nmol/l

0.49

130

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

101

251

2.10

9.73

1.6

1.4

5.71

5.95

nmol/l

0.17

244

(3001964) Herpes simplex virus Ag [Presence] in Specimen

138

385

1.87

9.70

1.8

1.3

—

(3019174) dRVVT (LA screen)

102

2.82

9.68

1.2

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

5.22

9.63

2.4

2.2

—

(37021550) Renin [Units/volume] in Plasma --upright

194

2.26

9.63

1.5

1.3

164.23

65.35

mu/l

0.52

151

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

984

6357

0.80

9.57

1.4

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

428

1592

1.41

9.35

1.6

7.96

7.54

mmol/l

3.04

404

1533

(3023199) Leukocytes [#/volume] in Pleural fluid

425

1581

1.41

9.29

1.5

1.4

3655.74

2527.42

e6/l

0.56

349

1078

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.29

9.25

1.0

1.1

2.70

4.40

u/l

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

3.78

9.23

1.0

1.1

21.32

23.36

u/ml

0.06

(3003888) Timothy IgE Ab [Units/volume] in Serum

747

3032

1.29

9.21

1.1

5.01

5.80

u/ml

0.65

397

1474

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

185

2.26

9.17

1.6

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

683

0.43

9.15

2.7

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

683

0.43

9.15

5.4

6.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

143

2.45

9.11

2.6

2.0

1.24

1.56

mmol/l

0.37

112

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

140

2.46

9.09

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

190

2.23

8.99

1.1

1.2

2.74

13.58

u/ml

2.14

134

(3003338) MCHC [Mass/volume]

29622

157969

0.94

8.92

22.6

12.9

332.84

333.21

g/l

9.47

29360

156475

(3020650) Glucose [Presence] in Urine

638

0.42

8.88

1.3

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

3.08

8.78

1.3

23.71

16.55

pmol/l

0.48

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

410

1537

1.40

8.61

1.1

—

(3034614) HLA Ag [Interpretation]

4.82

8.58

1.4

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

169

524

1.69

8.46

1.2

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.76

8.40

1.3

457.30

491.18

nmol/l

0.09

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

121

340

1.86

8.39

1.3

1.2

587.57

191.47

ug/l

0.67

177

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

121

2.50

8.29

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

106

2.61

8.22

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

468

1809

1.35

8.18

1.5

1.4

32.81

33.68

g/l

0.71

441

1630

(3032352) Blasts [#/volume] in Cerebral spinal fluid

113

2.54

8.11

3.8

2.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.92

8.09

2.0

1.6

53.07

43.29

umol/l

0.81

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

3.03

8.00

3.2

2.9

25.09

59.98

pmol/l

0.32

(3017461) Flecainide [Moles/volume] in Serum or Plasma

3.17

7.93

1.6

1.4

0.59

0.71

umol/l

0.61

(21491868) Cryoglobulin [Mass/volume] in Serum

144

438

1.72

7.76

1.3

1.1

0.25

0.23

g/l

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

113

320

1.84

7.70

1.9

1.2

12.79

13.36

g/l

0.24

243

(3012494) Peanut IgE Ab [Units/volume] in Serum

126

370

1.78

7.65

1.1

3.48

7.55

u/ml

0.70

214

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1625

7291

1.17

7.63

2.0

1.8

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

163

2.21

7.61

2.6

2.5

74.25

68.75

pmol/l

0.09

146

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

111

314

1.85

7.59

1.2

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.07

7.57

1.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

225

771

1.53

7.56

1.9

2.0

3.11

3.53

ug/l

0.25

206

709

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

788

3303

1.25

7.56

1.5

1.4

152.16

129.31

pmol/l

0.43

768

3238

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

819

3451

1.24

7.50

1.1

2.39

2.38

u/ml

0.01

418

1618

(4094501) Cardiovascular stress test using bicycle ergometer

908

3870

1.23

7.48

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

1004

4325

1.22

7.46

3.3

2.9

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.08

7.42

3.4

3.2

—

(3052592) Norovirus Ag [Presence] in Stool

243

1.96

7.38

1.4

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

559

3729

0.78

7.30

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

268

962

1.46

7.23

1.3

16.74

14.36

u/l

0.32

241

907

(3051651) Icteric interference index of Serum or Plasma

228

796

1.50

7.06

4.6

3.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

131

400

1.71

7.01

2.7

1.5

12214.69

10382.23

e6/l

0.10

189

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

168

548

1.60

7.01

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.55

6.95

3.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.53

6.93

1.0

1.1

9.04

12.54

u/l

0.56

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

167

2.13

6.88

1.8

1.7

1.59

1.84

mg/l

0.62

137

(3020618) Glucose [Moles/volume] in Synovial fluid

3.67

6.87

1.0

1.1

4.94

4.84

mmol/l

0.06

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

306

1139

1.40

6.81

1.2

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

263

1.87

6.70

1.1

1.25

0.78

u/ml

0.31

249

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

102

2.46

6.69

1.1

1.2

1.43

1.70

umol/24h

0.96

102

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

282

1.83

6.69

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

210

1602

0.68

6.68

2.7

2.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

139

2.22

6.60

1.6

1.5

6.02

499167.84

nmol/l

1.73

119

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

284

1.82

6.55

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

284

1.82

6.55

1.2

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

273

1.84

6.53

1.5

1.2

23.49

47.91

g/l

0.63

221

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.62

6.52

1.0

1.1

—

(3021788) Differential panel - Synovial fluid

634

2640

1.26

6.51

1.6

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

225

798

1.47

6.50

6.3

7.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.97

6.47

4.9

4.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

252

915

1.44

6.46

1.1

6.49

9.25

iu/ml

1.10

273

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

303

1140

1.39

6.38

4.0

3.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

169

566

1.56

6.37

1.1

—

(40762814) Titanium [Mass/volume] in Blood

181

2.02

6.26

2.4

3.30

3.97

ug/l

0.52

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

317

1206

1.37

6.25

2.0

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

268

992

1.41

6.21

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

268

992

1.41

6.21

1.1

1.2

—

(3019977) pH of Arterial blood

238

862

1.44

6.20

2.8

2.4

7.41

7.42

0.42

356

(3013293) Extractable nuclear Ab [Presence] in Serum

200

1.96

6.18

1.8

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

287

1077

1.39

6.15

1.3

1.2

186.60

197.87

titre

0.07

169

(3044009) aPTT.lupus sensitive (LA screen)

120

2.26

6.13

1.2

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

286

1074

1.39

6.11

1.3

1.2

153.85

153.64

titre

0.00

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

158

2.08

6.10

11.3

6.7

0.38

0.30

umol/l

0.78

141

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

267

991

1.41

6.10

1.1

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

291

1.78

6.10

1.9

1.5

42.87

34.65

u/l

0.19

259

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

265

983

1.41

6.08

1.1

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

140

454

1.61

6.05

3.4

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

140

454

1.61

6.05

3.4

2.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

265

984

1.41

6.04

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

119

370

1.68

6.04

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

697

2961

1.23

6.02

1.1

1.94

2.20

u/ml

0.30

375

1335

(3051101) Glucose [Moles/volume] in Cord blood

303

0.33

6.02

4.1

6.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

264

982

1.41

5.97

1.1

1.2

—

(3047189) Immunofixation for 24 hour Urine

165

559

1.54

5.95

1.6

1.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

3.48

5.95

1.0

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

3.70

5.91

1.4

1.3

107.81

122.90

nmol/l

0.18

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.61

5.84

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

693

2958

1.23

5.75

1.1

0.80

1.22

u/ml

1.53

282

1166

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

194

687

1.48

5.71

1.2

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

8639

42854

1.06

5.69

1.7

1.6

1.50

1.36

mmol/l

25.63

7798

35063

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

421

1697

1.30

5.67

1.4

8.08

7.87

mmol/l

0.49

414

1633

(3023436) Glucagon [Mass/volume] in Serum or Plasma

2.78

5.67

1.8

1.6

196.78

188.09

ng/l

0.26

(3025577) Chromium [Mass/volume] in Blood

211

761

1.45

5.67

2.0

2.1

2.29

2.32

ug/l

0.03

172

659

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

135

2.13

5.65

1.0

0.02

0.69

u/ml

1.27

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

552

2310

1.25

5.51

1.1

3.27

2.81

u/ml

0.30

242

1325

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

133

2.12

5.51

2.0

1.6

—

(3020491) Glucose [Moles/volume] in Blood

285

1091

1.37

5.48

1.8

1.9

6.90

6.71

mmol/l

0.38

221

880

(3035880) pH of Pleural fluid

210

763

1.44

5.45

1.3

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

240

1.81

5.44

1.4

1.2

310.62

332.68

pmol/l

0.18

183

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

452

2977

0.79

5.44

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

225

1.83

5.43

2.8

3.0

2378.84

1729.94

u/l

0.18

206

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.54

5.42

1.1

—

(4281824) Cell count and differential, peritoneal fluid

247

1762

0.73

5.39

1.3

1.1

—

(3002619) Bacteria identified in Specimen by Culture

287

1.73

5.39

1.3

1.2

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.80

5.37

1.1

71.80

15.75

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.80

5.37

1.1

21.72

20.94

u/ml

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

191

684

1.46

5.35

1.2

1.1

4.07

4.28

iu/ml

0.07

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.21

5.34

1.0

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

8.95

5.31

1.1

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.51

5.29

1.0

0.32

0.93

u/ml

0.43

(3049233) Organic acids panel - Urine

6.64

5.24

1.2

1.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

2.47

5.17

1.3

1.2

366.28

221.30

u/l

0.21

(3041806) Other cells [#/volume] in Blood by Manual count

124

991

0.65

5.12

1.5

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

150

519

1.51

5.00

1.4

64.55

62.37

0.32

128

439

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

224

1.79

4.98

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

154

1.97

4.92

2.8

2.5

—

(3029612) Listeria sp Ab [Titer] in Serum

4.35

4.88

1.3

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

137

2.02

4.84

3.5

2.4

1.73

1.29

mg/l

0.41

(3028308) Erythrocytes [#/volume] in Pleural fluid

365

1478

1.29

4.83

1.5

1.4

45971.45

50197.81

e6/l

0.14

250

825

(3011897) Casein IgE Ab [Units/volume] in Serum

189

1.85

4.79

1.1

1.3

0.11

2.52

u/ml

1.98

184

(40761539) Cells [Type] in Urine sediment by Light microscopy

119

395

1.57

4.78

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

247

1.73

4.75

1.3

1.2

1.59

1.66

mmol/l

0.16

142

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.35

4.69

1.1

1.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

362

2397

0.79

4.63

2.1

1.7

89.74

89.65

0.09

355

2360

(3014133) Dog dander IgE Ab [Units/volume] in Serum

599

2582

1.21

4.61

1.1

1.0

4.25

4.47

u/ml

0.10

317

1151

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

6.26

4.41

1.2

1.1

1.38

1.22

mg/l

—

(3000285) Sodium [Moles/volume] in Blood

154

1.90

4.35

1.3

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

569

3566

0.83

4.34

3.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

181

1.82

4.30

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.20

4.25

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

706

3118

1.18

4.22

2.2

0.00

g/l

0.14

625

2840

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4090

19985

1.07

4.19

1.6

1.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

191

1.78

4.14

6.5

6.4

—

(40759632) Porphyrins [Mass/mass] in Stool

7.45

4.13

1.0

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

708

3138

1.18

4.07

1.8

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.25

4.06

1.1

1.0

—

(4034850) Laboratory test

1159

6837

0.88

4.03

11.0

8.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.29

3.99

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

6.52

3.84

1.1

1.0

1502.00

1243.75

titre

—

(3000492) Spirometry study

3419

16658

1.08

3.81

1.5

1.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

293

1.59

3.79

1.2

36.19

35.88

mg/l

0.00

216

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

142

517

1.43

3.79

1.0

—

(3014891) Appearance of Pleural fluid

136

1.88

3.76

1.4

1.3

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.82

3.71

1.1

1.0

245.14

221.25

pmol/l

0.09

(3036782) Glucose [Moles/volume] in Pleural fluid

328

1363

1.26

3.65

1.4

1.3

6.54

6.08

mmol/l

2.26

299

1257

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

272

1.59

3.62

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

112

1.96

3.62

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

2.10

3.61

1.1

1.0

0.62

1.17

u/ml

0.86

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

8.35

3.57

4.9

8.0

9.00

3.80

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

109

1.96

3.57

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

140

1015

0.72

3.55

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

162

612

1.38

3.54

1.2

1.3

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.19

3.53

1.0

1.1

5.18

8.52

u/ml

0.57

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.00

3.49

1.3

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

214

1.66

3.48

1.0

85.62

77.43

ug/l

0.83

180

(3042010) Triglyceride [Moles/volume] in Pleural fluid

179

1.72

3.45

1.3

1.2

1.30

1.54

mmol/l

0.11

107

(40762887) Creatinine [Moles/volume] in Blood

3.99

3.42

1.2

1.1

—

(3012501) Base excess in Blood by calculation

733

4404

0.87

3.42

4.6

3.7

2.55

2.49

mmol/l

0.21

481

2959

(3013290) Carbon dioxide [Partial pressure] in Blood

733

4404

0.87

3.42

4.6

3.7

5.06

5.00

kpa

1.61

720

4307

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

141

1014

0.72

3.42

1.4

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

100

1.98

3.41

2.9

2.1

15.44

16.30

0.05

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

123

447

1.44

3.36

1.1

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

192

753

1.33

3.34

1.1

166.18

216.17

iu/ml

1.86

192

743

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.76

3.25

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

131

486

1.41

3.22

1.2

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.39

3.18

2.3

2.6

3.53

1.69

mu/l

0.48

(3000330) Specific gravity of Urine by Test strip

1290

6069

1.11

3.18

3.1

2.9

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.13

3.14

1.0

0.10

0.30

u/ml

0.68

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

157

1094

0.75

3.12

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.68

3.10

11.0

7.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1028

4783

1.12

3.10

3.0

3.6

736.22

2910.77

u/ml

0.96

897

4126

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

680

3082

1.15

3.06

2.3

2.2

0.00

g/l

-0.00

620

2832

(3023383) Lactate [Moles/volume] in Pleural fluid

107

387

1.44

3.04

1.4

1.2

3.71

3.74

mmol/l

0.03

101

356

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

203

1.62

3.00

1.9

3.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.61

2.96

2.2

2.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

227

930

1.27

2.92

1.8

1.7

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.09

2.90

1.1

1.0

84.18

48.95

u/l

0.32

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.10

2.86

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.61

2.81

1.0

—

(3027315) Oxygen [Partial pressure] in Blood

747

4414

0.88

2.80

4.6

3.7

8.65

kpa

0.02

733

4317

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

143

1.72

2.79

1.4

72.64

69.83

0.22

116

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.37

2.76

1.2

1.0

—

mmol/l

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

4.01

2.76

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

112

417

1.40

2.76

2.5

1.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

162

641

1.32

2.73

2.1

2.2

78.64

130.84

ug/min

0.47

123

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

472

2102

1.17

2.71

1.0

0.34

0.55

u/ml

0.57

139

435

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1241

5885

1.10

2.69

1.5

1.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

102

1.84

2.69

2.4

2.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

168

670

1.31

2.69

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

110

1.80

2.66

1.1

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

3.13

2.65

1.0

0.12

0.01

u/ml

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

3.13

2.65

1.1

36.34

33.95

0.11

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

361

2241

0.84

2.65

3.6

3.3

46.27

41.97

u/ml

0.16

353

2157

(3033942) Copper [Moles/time] in 24 hour Urine

2.32

2.65

1.2

1.1

0.24

0.42

umol/24h

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

250

1.50

2.56

1.9

2.00

4.54

ug/l

0.75

164

(40758358) Immune stain study

2.27

2.54

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.98

2.48

1.0

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

111

0.38

2.42

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.92

2.40

1.3

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

123

1.70

2.34

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

486

2202

1.15

2.30

1.5

1.4

—

(3012441) Differential panel - Pleural fluid

335

1474

1.19

2.29

1.5

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

202

1.52

2.27

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.39

2.27

6.4

5.5

1.11

1.70

mg/l

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

232

1.49

2.25

1.4

15.48

10.43

0.59

134

(3000919) Neutrophils/100 leukocytes in Pleural fluid

110

425

1.35

2.24

1.3

1.4

21.42

22.39

0.13

101

387

(3007700) Barley IgE Ab [Units/volume] in Serum

2.05

2.24

1.0

0.55

0.17

u/ml

—

(3041184) Isoniazid [Presence] in Urine

3.80

2.20

3.0

2.1

—

(3035285) Chloride [Moles/volume] in Venous blood

256

1606

0.83

2.18

2.4

2.1

104.55

105.50

mmol/l

2.05

256

1589

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

223

1413

0.82

2.13

1.4

—

(3001729) Color of Synovial fluid

134

0.43

2.12

2.6

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

684

3189

1.12

2.12

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

684

3191

1.12

2.10

1.4

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

439

1990

1.15

2.10

6.7

6.1

7.40

7.10

mmol/l

0.83

375

1636

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

4.06

2.08

1.4

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

170

707

1.26

2.06

1.2

104.97

86.09

u/l

0.73

150

614

(3041354) Potassium [Moles/volume] in Venous blood

258

1606

0.84

2.05

2.4

2.1

4.05

4.07

mmol/l

0.21

258

1590

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

137

1.60

2.01

1.2

1.1

15.73

19.95

u/l

1.12

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.84

1.93

1.3

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.84

1.93

1.2

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

255

1116

1.19

1.91

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

137

561

1.28

1.91

1.8

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

137

561

1.28

1.91

1.8

1.4

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.94

1.90

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.94

1.90

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.94

1.90

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.94

1.90

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.94

1.90

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.94

1.90

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.74

1.89

1.1

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.24

1.89

1.5

1.2

—

(3044336) Cobalt [Moles/volume] in Urine

2.24

1.89

4.1

2.2

50.32

18.95

nmol/l

1.51

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

153

1.54

1.84

1.1

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

145

1.55

1.83

1.4

1.5

—

(3025130) Human papilloma virus identified in Specimen

403

2398

0.88

1.82

1.7

—

(40768795) Lymph node Pathology biopsy report

275

1682

0.85

1.81

1.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

2.41

1.76

1.2

1.0

74.78

65.24

1.64

(3012989) Citrate [Moles/time] in 24 hour Urine

2.41

1.76

1.8

1.2

2.34

2.23

mmol/24h

0.08

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

2.09

1.74

1.0

0.27

0.03

u/ml

0.56

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.21

1.74

1.0

0.00

0.06

u/ml

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.26

1.69

1.1

1.6

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.61

1.68

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

529

2472

1.12

1.66

1.1

1.0

6.42

5.77

u/ml

0.19

236

985

(3032641) Amino acids panel - Urine

2.78

1.65

1.4

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

121

499

1.27

1.64

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

188

1.44

1.63

1.5

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.48

1.62

2.1

2.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

386

1774

1.14

1.60

1.9

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

203

1253

0.84

1.55

1.3

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

3.73

1.50

1.2

1.1

37.98

41.29

nmol/24h

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.61

1.49

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.65

1.48

1.1

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.67

1.48

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

101

414

1.27

1.47

1.2

—

(3013762) Body weight Measured

1.89

1.46

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.03

1.45

4.0

5.8

0.34

0.22

mmol/l

0.59

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.37

1.44

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

361

1666

1.13

1.44

1.4

1.3

184.73

199.37

pmol/l

0.20

361

1666

(3022670) pH of Venous cord blood

1.90

1.40

1.1

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

101

1.55

1.35

5.3

4.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

151

655

1.20

1.35

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

280

1665

0.88

1.34

1.4

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

562

2671

1.10

1.34

1.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

153

1.43

1.32

2.9

2.1

65.30

56.66

0.62

(40768793) Breast Pathology biopsy report

694

3337

1.09

1.29

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.54

1.29

1.1

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1914

10471

0.95

1.28

1.7

1.6

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

332

1.27

1.23

2.3

2.7

7.34

7.22

mmol/l

0.09

165

(3035320) C reactive protein [Mass/volume] in Body fluid

260

1190

1.14

1.23

2.9

2.0

—

(40768800) Prostate Pathology biopsy report

560

3185

0.92

1.21

1.2

—

(3044007) Cell count panel - Peritoneal fluid

384

1.25

1.21

2.4

1.6

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.82

1.19

1.1

1.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

184

1.36

1.16

1.4

22.24

24.33

0.15

140

(3019897) Erythrocyte distribution width [Ratio] by Automated count

517

2942

0.92

1.15

3.1

2.2

13.14

13.11

0.33

511

2896

(3022475) Manganese [Moles/volume] in Blood

1.51

1.14

1.1

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

155

687

1.18

1.14

1.2

30.67

24.17

u/l

0.45

136

589

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.83

1.13

1.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1955

9775

1.05

1.09

9.9

6.3

24.82

24.71

mmol/l

0.65

1944

9673

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

357

1.24

1.09

2.9

2.2

121.85

93.66

ng/l

0.87

163

(40768806) Pleura Pathology biopsy report

318

1490

1.11

1.06

1.5

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.74

1.05

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.70

1.05

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.55

1.03

1.1

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.50

1.02

1.6

1.2

319.92

317.94

umol/24h

0.02

(3007456) Orange IgE Ab [Units/volume] in Serum

1.91

1.01

1.0

0.12

0.07

u/ml

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

185

1.33

1.00

1.1

1.7

—

45.11

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.67

0.99

1.4

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

554

3116

0.93

0.97

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

191

1.31

0.96

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

128

1.39

0.95

2.0

3.0

0.56

0.50

u/field

0.11

128

(3003740) Influenza virus B Ag [Presence] in Specimen

555

3117

0.93

0.95

1.1

—

(4212803) Bone marrow aspirate examination

124

0.63

0.95

1.3

1.0

—

(40767503) Oxygen content in Capillary blood by calculation

784

3845

1.07

0.94

2.8

2.3

16.83

16.61

0.81

525

1776

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.79

0.93

1.3

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.53

0.92

1.0

0.38

0.26

u/ml

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.49

0.90

1.1

1.4

—

(3018291) Platelet Ab [Presence] in Serum

1.86

0.87

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

132

594

1.16

0.87

2.7

3.0

—

(3012565) Volume of 24 hour Urine

154

916

0.88

0.85

2.2

1990.24

2000.74

0.04

147

834

(3023420) DNA double strand Ab [Units/volume] in Serum

327

1561

1.09

0.82

1.7

1.5

42.86

30.58

iu/ml

0.48

(3015350) Toxocara sp Ab [Presence] in Serum

2.37

0.79

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.37

0.79

1.2

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

2.37

0.79

1.6

1.4

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

2.37

0.79

1.0

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.81

0.79

1.0

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

134

1.32

0.76

1.1

15.33

16.20

iu/ml

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.92

0.76

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

206

967

1.11

0.75

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

247

1171

1.10

0.74

1.8

1.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

294

0.80

0.74

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.52

0.73

1.4

1.5

0.22

0.38

u/l

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

170

791

1.12

0.72

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.62

0.72

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.74

0.70

1.4

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

150

1.29

0.70

1.3

1.5

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

109

494

1.15

0.70

1.4

3.65

2.47

0.61

422

(3008607) Semen analysis panel

164

1.27

0.69

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

546

2687

1.06

0.66

2.8

2.7

7.21

7.73

mmol/l

2.71

530

2636

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.42

0.64

1.0

1.1

1.70

4.18

u/ml

0.77

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.64

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.42

0.63

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

269

1294

1.09

0.63

1.5

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

135

0.73

0.61

3.7

1.9

8.67

19.43

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.53

0.58

1.0

1.88

0.06

u/ml

—

(46235168) Fasting glucose [Moles/volume] in Blood

232

0.81

0.57

1.2

2.2

9.91

7.00

mmol/l

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.46

0.56

1.0

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

256

1.18

0.55

3.9

4.6

60.87

50.95

ug/min

0.38

211

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.58

0.55

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

538

2952

0.95

0.54

2.1

1.7

1.79

1.78

mmol/l

0.06

527

2887

(3024891) Influenza virus A+B Ag [Presence] in Specimen

906

4549

1.04

0.53

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

542

0.89

0.51

2.7

1.8

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

160

0.78

0.51

1.7

1.6

114.22

111.09

ug/l

0.04

128

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.68

0.51

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

292

1427

1.07

0.49

4.1

3.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.30

0.49

1.1

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

107

1.27

0.48

1.2

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.46

0.47

1.4

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.46

0.47

1.0

1.1

2.14

2.36

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3986

20476

1.02

0.46

1.5

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

127

1.23

0.45

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

225

0.83

0.45

1.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.42

0.44

1.1

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.43

0.0

1.3

—

1.38

—

(3004451) EKG impression Narrative

136

774

0.92

0.43

1.4

1.2

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.42

0.0

1.0

—

172.80

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

149

0.81

0.41

1.3

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.45

0.40

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

197

1.17

0.39

2.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

106

1.23

0.38

1.4

1.2

67.34

112.16

ug/l

1.06

(3006969) Lambda light chains [Mass/volume] in Urine

1.40

0.38

1.1

1.0

0.02

0.10

g/l

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

112

1.21

0.35

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

205

1133

0.94

0.33

1.1

0.83

2.16

u/ml

1.05

328

(3015076) Soybean IgE Ab [Units/volume] in Serum

192

1060

0.94

0.31

1.1

1.0

0.62

0.76

u/ml

0.21

219

(3035082) Kappa light chains [Mass/volume] in Urine

1.33

0.30

1.2

1.1

0.02

0.35

g/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

465

2343

1.04

0.30

1.4

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

139

1.16

0.29

1.1

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

1.30

0.29

5.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

208

1141

0.95

0.28

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

141

1.15

0.26

1.1

1.0

-0.40

-1.99

mmol/l

—

(1002224) Polysomnography panel

1474

7567

1.02

0.24

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

207

1129

0.96

0.23

1.1

1.99

4.33

u/ml

0.41

264

(3010422) Chicken meat IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

0.97

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.25

0.21

2.2

2.4

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.20

0.20

1.2

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

230

1.09

0.19

1.0

—

(3006598) pH of Arterial cord blood

145

1.12

0.19

1.1

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

113

0.88

0.17

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.15

0.15

1.0

1.1

222.89

271.42

nmol/l

—

(3011325) HIV 1+2 Ab [Presence] in Serum

101

0.88

0.15

1.2

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1050

5417

1.01

0.13

1.7

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1390

7185

1.01

0.12

1.5

1.4

—

(3006462) Nitrate [Presence] in Urine

130

700

0.97

0.11

4.0

2.4

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

1.19

0.10

1.2

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.04

0.09

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

535

2824

0.99

0.08

1.4

1.3

4.05

4.06

ug/l

0.01

483

2568

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

275

1.04

0.08

2.3

2.4

20.14

30.58

mg/l

0.58

(3003577) Lead [Moles/volume] in Blood

142

1.07

0.08

1.3

1.6

0.13

0.24

umol/l

1.08

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.85

0.06

1.0

167.67

166.02

g/l

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

118

1.06

0.06

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

242

1.03

0.05

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

275

1.02

0.03

1.1

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

120

0.96

0.03

1.1

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.06

0.02

1.1

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

221

1146

1.01

0.02

1.4

30.42

32.99

nmol/l

0.56

195

1071

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

111

1.03

0.01

1.0

1.1

1.18

1.14

u/field

0.06

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.04

0.00

1.0

1.2

—

(3010421) pH of Blood

942

4914

1.00

0.00

4.6

3.6

7.41

7.42

5.43

770

4639

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.8

—

3.40

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

12.46

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_GENERAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS – General examination and investigation of persons without complaint and reported diagnosis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

General examination and investigation of persons without complaint and reported diagnosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for General examination and investigation of persons without complaint and reported diagnosis (Z21_GENERAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints